Tag: Chronic

  • Role of Alternative Medical Systems in Adult Chronic Kidney Disease Patients: A Systematic Review of Literature

    Role of Alternative Medical Systems in Adult Chronic Kidney Disease Patients: A Systematic Review of Literature

    Chronic kidney disease (CKD) is one of the leading causes of death globally, which affects 13.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of the world’s population [1]. With deterioration in renal function, this leads to the onset of CKD-related complications, such as uremia, anemia, and electrolyte disorders [2]. These complications often manifest as symptoms ranging from pruritus, pain, and insomnia to muscle cramps. This in turn has negative implications on patients’ quality of life [3,4]. Importantly as CKD patients approach end-stage renal disease (ESRD), the prevalence and severity of such symptoms increase [5].

    Despite medical breakthroughs and the advent of new therapies in the past decades, optimal treatments for some of the symptoms resulting from CKD-related complications remained unclear, possibly due to their complex pathophysiology. A case in point is uremic pruritus, which is found in around 20{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of pre-dialysis CKD patients and 40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of ESRD patients [6]. Although prevalent treatments include the use of emollients, gabapentin, and antihistamines, data related to their efficacy were often derived from small studies and their use is limited by adverse effects [7].

    The use of alternative medical systems (AMS) which forms a key pillar of complementary and alternative medicine (CAM) has increased in the past 20 years [8]. AMS is defined as “entire systems of health theory and practice that developed separately from conventional medicine” [9]. Notably, around 18{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of dialysis patients have utilized some form of AMS [10,11]. In addition, prescription of AMS therapies such as traditional Chinese medicine (TCM) by professional practitioners often aids in minimizing the risk of side effects, hence increasing their appeal as potential therapeutic alternatives [11].

    Prior studies have shown that AMS is effective in reducing symptoms such as pain, nausea, and fatigue in non-CKD patient populations. For instance the use of TCM formulas, such as Liu Junzi Tang and Xiao Banxia Plus Fuling have demonstrated efficacy in treating cancer-related pain and chemotherapy-related nausea and vomiting [12]. In addition, Chinese herbs such as Curcuma longa and Panax ginseng among patients with malignancies have shown efficacy in promoting apoptosis of cancer cells and inhibiting tumor metastasis [13]. Another study showed that a multi-modal Ayurvedic treatment approach was effective in reducing knee osteoarthritis symptoms, such as pain and stiffness, and improving function [14]. With increasing research supporting the use of AMS, this has led to a rise in healthcare institutions adopting and providing such integrated services which are supported by insurance coverage [15].

    Among CKD patients, multiple studies have also been conducted to assess the efficacy of AMS in the treatment of CKD-related conditions and symptoms such as uremic pruritis and anemia. For instance, a study that assessed the efficacy of homeopathy verum among CKD patients showed a reduction in pruritus symptoms by 49{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} after 30 days of treatment [16]. Another study that evaluated the use of TCM patients with glomerulonephritis showed improvement in hemoglobin after 24 weeks of therapy [16,17].

    Existing reviews which have assessed the role of AMS are currently limited to specific indications, such as uremic pruritus [18], use of subtypes of AMS in specific CKD subgroups, such as consumption of Chinese herbal medicine in diabetic kidney disease [19], and specific AMS therapies, such as use of Astragalus [20,21]. This review aimed to summarize and evaluate the broad roles and efficacy of AMS as potential alternative therapeutic options for CKD patients. Findings from the review will aid physicians in gaining a better understanding of the efficacy of AMS for CKD patients, which can aid in facilitating purposeful discussions with patients who are using or considering these therapies.

    Methods

    Protocol and Registration

    The protocol for this study was registered on Open Science Framework (https://osf.io/ymks8/) and was composed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and Synthesis without Meta-Analysis (SWiM) reporting guidelines [22,23].

    Information Sources and Search

    A literature search was conducted in MEDLINE, Embase, Scopus, CENTRAL, CINAHL, and PsycINFO. There was no start date restriction, and studies up to April 2022 were included. Key terms related to CKD, randomized controlled trials (RCT), and AMS were included in the searches. The search terms were adapted from other systematic reviews and the full search strategy is available in Appendix 1 [18,24-26].

    Eligibility Criteria

    With regards to inclusion criteria, full-text articles in English language which involved RCTs evaluating the use of AMS in adult CKD patients (>18 years old) were included. As defined by the National Center for Complementary and Integrative Health (NCCIH), AMS is a broad category encompassing a variety of medical modalities and refers to an entire system of theory and practice which developed separately from conventional medicine [15]. In this review, we included TCM, naturopathy, homeopathy, and ayurvedic medicine. Non-RCTs, case series, other systematic reviews, and meta-analyses were excluded.

    Description of Main Types of AMS

    TCM: TCM is a system of medical practice which originated in China and adopts a holistic approach to the medical treatment of a patient based on “syndrome differentiation.” It focuses on the integrity of the human body by emphasizing the intimate relationship between the body and its social and natural environment, as well as dynamic balance of movement [27]. The basic tenet of TCM is based on the flow and balance of vital energy, Qi, which flows through channels in the body called meridians that connect various organs and tissues [28]. Diseases are believed to be brought about by the imbalance of Qi. Hence, by restoring balance via acupoints or intake of herbs, TCM seeks to promote individual wellness and prevent diseases [29].

    Naturopathy: Naturopathy is a form of medical practice which is rooted in vitalism and folk medicine and, promotes natural and self-healing ideologies [30]. The unique attribute of naturopathic medicine lies in the reprioritization of the order of therapeutics with increased emphasis on preventive behaviors, lifestyle modifications, nutrition, and exercise, over medical or surgical interventions [31].

    Homeopathy: Homeopathy entails the therapeutic administration of substances derived from plants, minerals, or animals that produce effects that correspond to the clinical manifestation of diseases [32]. Its practice is centered on two following theories: “like cures like” and “law of minimum dose.” “Like cures like” refers to the belief that diseases can be treated with substances that produce similar symptoms in healthy individuals, and “law of minimum dose” refers to the belief that the lower the dose the greater its therapeutic efficacy [32].

    Ayurvedic medicine: Ayurvedic medicine is one of the oldest alternative medical systems which involves the use of therapeutics derived predominantly from plants, animals, minerals, diet, exercise, and lifestyle changes. Its therapies are centered on the principle of “Panchakarma,” which comprises five karmas (actions) to rejuvenate and remove toxins from one’s body [33].

    Study Selection and Data Collection Process

    Citations retrieved from the six databases were extracted into Endnote X9 software (Philadelphia, PA: Clarivate) and duplicated citations were removed. During the initial article screening, two independent reviewers (WY and SW) reviewed the titles and abstracts of articles to select relevant articles. Thereafter, the full texts of the identified articles were evaluated. All discrepancies during the article screening process were resolved by discussion with a third reviewer (JJ). Hand-searching of references within identified articles was also performed to enhance the comprehensiveness of the search. A standardized Microsoft Excel data collection form was used for data extraction, and details related to the study characteristics, studied indications of intervention, efficacy, and safety were collected.

    Management of Missing Data

    For studies with missing data, authors were contacted for clarification to enhance the comprehensiveness of this review. Missing information that could not be retrieved after two email reminders were labeled as unavailable.

    Risk of Bias in Individual Studies

    The Cochrane Risk of Bias tool version 2.0 (Oxford, England: Cochrane) was utilized in the assessment of the included RCTs [34]. Two independent reviewers (Teo and Chu) performed the risk of bias assessment (Appendix 2). The instrument comprises of the following five domains: risk of bias arising from the randomization process, deviations from intended interventions, missing outcome data, outcome measurement, and selection of reported results. Using the responses derived from the five domains, the overall risk of bias for the individual studies was rated as “low,” “some concerns,” or “high” risk of bias.

    Assessment of Heterogeneity

    Clinical and methodological heterogeneity of included studies were analyzed to evaluate if meta-analyses could be performed for specific interventions in this study. Clinical heterogeneity describes variation in characteristics of study participants, intervention, or outcomes while methodological heterogeneity describes variation in study design and risk of bias. This was performed by two independent reviewers (Yeam and Seng). In view of the clinical and methodological heterogeneity across the included studies, a narrative review of the RCTs was conducted.

    Synthesis of Data

    With regard to the efficacy of AMS interventions, the response rates and any changes in patients’ quality of life were recorded. Additionally, the safety profile of each intervention was evaluated and the reported prevalence, severity, and outcomes of adverse effects were tabulated. The adverse events reported in included studies were categorized using the Common Terminology Criteria for Adverse Events (CTCAE) [35].

    Summary Measures

    Descriptive statistics were utilized to summarize the characteristics of all included studies. The principal summary measures evaluated in this study were the studied indications, efficacy of each AMS, and safety profile of each AMS.

    Results

    Study Selection

    Out of 14,583 retrieved citations, 33 full-text articles were included in this review. The inclusion and exclusion criteria for the studies are shown in Figure 1. The percentage of agreement of articles between the reviewers was 94.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and all disagreements were resolved after discussion.

    Study Characteristics

    Types of AMS studied: Table 1 shows the characteristics of included studies. Among the four main types of AMS, TCM was the most studied (n=20, 60.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [3,7,17,36-52], followed by Ayurveda (n=6, 18.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [53-58], naturopathy (n=5, 15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [59-63], and homeopathy (n=2, 6.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [16,64].

    Study (year of publication) Study design Number of patients in treatment and control arm Indication for use of intervention Treatment Comparator Country Patient population Mean age of patients (SD) Gender (male) ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Traditional Chinese medicine (n=20)
    Li et al. (2015) [41] Double-blinded parallel arm T1:66, C1:32, T2:56, C2:26 Renal function 8 g TSF granules and ARB BID x 24 weeks 8 g placebo TID and ARB BID x 24 weeks China Non-dialysis CKD patients T1:59.5 (10.1), C1:56.7 (9.3), T2:58.9 (9.0), C2:60.8 (10.0) T1:54.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C1:53.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, T2:58.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C2:53.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ma et al. (2013) [43] Parallel arm T:25, C:20 Renal function 150 mL ZSTL solution BID x 3 months 10 mg benazepril QD x 3 months China Early DN patients T:57, C:57 T:40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Wang et al. (2012) [17] Double-blinded parallel arm T1:192, T2:191, C:189 Renal function T1: TCM granules BID x 24 weeks, T2: TCM granules BID and 10mg benazepril QD x 24 weeks 10 mg benazepril QD and TCM placebo TID x 24 weeks China CKD stage 3 T1:47.3 (10.9), T2:49.3 (11.4), C:49.0 (10.5) T1:54.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, T2:47.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:47.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Yu et al. (2017) [50] Single-blinded parallel arm T:28, C:25 Renal function Acupuncture at Li4, ST36 and K13 acupoint QD x 3 months Sham acupuncture QD x 3 months China CKD stage 2-4 T:58.5, C:61.0 T:89.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:88.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Zhao et al. (2020) [52] Double-blinded parallel arm T:171, C:172 Renal function Herbal granules TID x 6 months Placebo granules x TID 6 months China CKD stage 3 T:51.89 (13.12), C:52.03 (12.62) T:62.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:70.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Xiang et al. (2016) [47] Parallel arm T:51, C:51 Renal function QDDHGa tablets BID x 12 weeks ARB tablets (minimum dosage) China DN patients T:57.21 (13.20), C:58.16 (11.59) T:24{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:22{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Xu et al. (2016) [49] Double-blinded parallel arm T:91, C:86 Renal function 500 mg GS-Rb1 (ginseng extract) QD x 6 months  Placebo tablets QD x 6 months China CKD stage 2-3 T:59.2 (8.5), C:58.4 (7.5) T:72.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:70.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Chen et al. (2013) [37] Parallel arm T:95, C:95 Proteinuria 9.6 g of Shenqi particle TID x 48 weeks Routine care China Non-dialysis CKD patients T:49 (14), C:53 (12) T:36.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:68.42{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ge et al. (2013) [39] Parallel arm T:34, C:31 Proteinuria  40 mg TWHF TID x 3 months followed by 20 mg TWHF TID x 3 months 80 mg valsartan BID x 6 months China DN patients T:51.9 (9.8), C:51.0 (8.9) T:58.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:54.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Li et al. (2020) [42] Double-blinded parallel arm T:735, C:735 Proteinuria Huangkui capsule TID x 12 months Losartan potassium tablet QD and placebo capsules TIW x 12 months China CKD stage 1-3a T:37.7 (10.9), C:37.1 (10.4) T:48.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:46.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Zhang et al. (2014) [51] Parallel arm T1:133, T2:136, C:135 Proteinuria T1: Huangkui capsule TID x 6 months, T2: Huangkui capsule TID and Losartan potassium tablet QD x 6 months  Losartan tablet potassium QD x 6 months  China Non-dialysis CKD patients T1:37.3 (12.5), T2:37.1 (11.1), C:38.1 (12.7) T1:50.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, T2:47.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:53.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Xiong et al. (2020) [48] Parallel arm T:62, C:62 Proteinuria 60 mg TWHF and 160 mg valsartan QD x 24 weeks 160 valsartan QD x 24 weeks China Non-dialysis CKD patients T:50.3 (11.8), C:49.6 (12.3) T:69.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:72.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Che-Yi et al. (2005) [36] Double-blinded parallel arm T:20, C:20 Uremic pruritus Acupuncture at Quchi (L11) acupoint TIW x 1 month Sham acupuncture TIW x 1 month China ESRD T:62.4 (9.1), C:63.2 (7.5) T:45.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:50.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Gao et al. (2002) [38] Double-blinded parallel arm T:34, C:34 Uremic pruritus Acupuncture at Quchi (L11) and Zusanli (ST 36) acupoint BIW x 1 month Sham acupuncture BIW x 1 month China ESRD 43.6 59.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Nahidi et al. (2018) [7] Single-blinded parallel arm T:15, C:11 Uremic pruritus Acupuncture at various acupoints TIW x 6 weeks Sham acupuncture TIW x 6 weeks Iran HD T:54.7 (11.4), C:41.4 (16.2) T:60{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:73{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ono et al. (2015) [3] Parallel arm T:23, C:17 Fatigue, insomnia, itchiness, and pain Acupuncture QIW x 2 months Routine care Japan HD T:70.0 (9.6), C:67.3 (13.0) NI
    Su et al. (2009) [44] Parallel arm T:31, C:30 QoL Infrared stimulation of Qihai (RN6), Kuamyuan (RN4) and Chungchi (RN3) TIW x 3 months Heat pad therapy to acupoints TIW x 3 months China ESRD T:61.07 (13.9), C:58.6 (12.6) T:51.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:56.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Wang et al. (2019) [45] Single-blinded parallel arm T:40, C:40 Wnt/β-catenin signaling pathway Qingshen granules TID x 3 months Placebo granules TID x 3 months China CKD stage 3-5 T:52.1 (10.4), C:54.9 (9.2) T:55{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:48{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Wang et al. (2020) [46] Parallel arm T:136, C:146 Immune function Qingshen granules TID x 3 months Routine care China CKD stage 3-5 T:54.0 (10.5), C:51.8 (12.0) T:55.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:57.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Li et al. (2009) [40] Parallel arm T:32, C:32 Vascular endothelial function TBN tablets (gingko extract) TI x 8 weeks Routine care China Early DN patients T:66.5 (71.1), C:67.2 (7.2) T:53.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ayurveda (n=6)
    Alam et al. (2020) [53] Parallel arm T:70, C:66 Renal function Sativa oil QD and alpha-keto amino acid tablets TID x 3 months Alpha-keto amino acid tablets TID x 3 months India CKD stage 3-4 T:49.2, C:48.8 T:58.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:51.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Fallahzadeh et al. (2012) [54] Double-blinded parallel arm T:30, C:30 Renal function 140 mg silymarin tablet QD x 3 months Placebo tablet QD x 3 months Iran Non-dialysis CKD patients T:55.9 (8.3), C:57.6 (7.5) T:50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:43.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Hoseini et al. (2019) [55] Parallel arm T:22, C:22 Renal function Camel milk BID x 3 months Routine care Iran CKD stage 3-4 56.7 (11.8) 52.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Khajehdehi et al. (2011) [56] Double-blinded parallel arm T:28, C:28 Renal function 140 mg silymarin TID x 3 months Placebo tablet TID x 3 months Iran Non-dialysis CKD patients T:55.9 (8.3), C:57.6 (7.5) T:50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:43.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Makhlough et al. (2010) [57] Double-blinded parallel arm T:17, C:17 Uremic pruritus 0.03{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} capsaicin ointment QID x 4 weeks Placebo ointment QID x 4 weeks Iran ESRD 57 (18.6) 41.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Pingali et al. (2020) [58] Double-blinded parallel arm T1:18, T2:18, C:19 Hyperuricemia T1:500 mg of beleric capsule taken QD T2: 1000 mg of beleric capsule taken QD C:40 mg of febuxostat taken QD India CKD stage 2-3 T1:53.2 (8.9), T2:50.8 (8.8), C:51.0 (9.8) T1:72.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, T2:77.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:73.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Naturopathy (n=5)
    Khan et al. (2014) [60] Double-blinded parallel arm T:80, C:80 Malnutrition  Alpha-keto amino acid tablets TID x 3 months Placebo tablets TID x 3 months India Non-dialysis CKD patients T:45.0, C:45.0 T:59.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:57.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Prakash et al. (2004) [61] Double-blinded parallel arm T:21, C:19 Malnutrition  Keto amino acid tablets QD x 9 months Placebo tablets QD x 9 months India CKD stage 3-4 T:52.8 (14.1), C:55.9 (17.6) T:55.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:43.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Sedaghattalab et al. (2021) [62] Double-blinded parallel arm T:22, C:23 Inflammation Watercress extract QD x 1 month Placebo extract QD x 1 month Iran HD T:58.9 (16), C:63.1 (13) NI
    Zare et al. (2019) [63] Double-blinded parallel arm T:19, C:21 Inflammation Garlic extract tablets TIW x 2 months Placebo tablets TIW x 2 months Iran PD T:56.0 (16.1), C:52.8 (18.8) T:42.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:42.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Boldaji et al. (2019) [59] Crossover trial T:22, C:19 Hypertension, stress, and inflammation Pomegranate juice TIW x 2 months Routine care Iran ESRD 47.8 (13.3) 61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Homeopathy (n=2)
    Cavalcanti et al. (2003) [16] Double-blinded parallel arm T:11, C:9 Uremic pruritus Homeopathic verum medicationb administered Placebo medication administered Brazil HD T:47, C:57 T:64{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:56{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Silveira et al. (2019) [64] Double-blinded parallel arm T:18, C:14 Renal function Brazilian green propolis pills BID x 3 months Placebo pills BID x 3 months Brazil CKD stage 1-5 T:52.8 (14.1), C:55.9 (17.6) T:55.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:43.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

    Overview of study design and patient characteristics in included studies are as follows: the majority of the studies were conducted in Asia (n=31, 93.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), whereas most of the studies were performed in China (n=18, 54.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). Out of all reviewed studies, 20 (60.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) were blinded to randomized controlled trials. The sample size was greater than 50 patients in 21 (63.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) trials (Table 1). Non-dialysis patients were recruited in seven studies (21.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), whereas ESRD patients were recruited in five studies (15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). The average duration of follow-up for all studies was 4.9 months (Table 2).

    Study (year of publication) Indication for use of intervention Treatment (dose and duration if available) Comparator (dose and duration if available) Tool(s) used to assess outcomes Outcome Improvement symptoms (yes / no) Percentage reductiona/improvement in symptoms (if available) Follow-up duration
    Traditional Chinese medicine (n=20)
    Li et al. (2015) [41] Renal function 8 g TSF granules TID and ARB BID x 24 weeks 8 g placebo TID and ARB BID x 24 weeks WHOQOL-BREF, DQOL UAER (μg/min) (pre vs post): 105.39±77.29 vs 88.37±108.46, p=0.021 Yes -16.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (UAER) 6 months
    24 h urinary protein (g/24 h) (pre vs post): 1.12±0.75 vs 0.91±0.90, p=0.017 -18.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (24 h urinary protein)
    Ma et al. (2013) [43] Renal function 150 mL ZSTL solution BID x 3 months 10 mg benazepril QD x 3 months Radioimmunoassay, ELISA HbA1c ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (baseline vs mean change from baseline): 10.68 (8.48, 13.96) vs -4.29 (-5.85, -2.79), p<0.05. Yes -40.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (HbA1c) 9 months
    UAER (μg/min) (baseline vs mean change from baseline): 211.52 (164.58, 243.89) vs -106.99 (-121.29, -85.55), p<0.05 -50.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (UAER)
    SCr (μmol/L) (baseline vs mean change from baseline): 87.17 (70.59, 110.25) vs -3.33 (-11.02, 2.15), p<0.05 -3.82{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr)
    CCR (mL/min) (baseline vs mean change from baseline): 139.86 (129.58, 149.52) vs -9.22 (-13.42, -5.82), p <0.05 -6.59{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (CCR)
    Wang et al. (2012) [17] Renal function T1: TCM granuleb BID x 24 weeks. T2: TCM granuleb BID and 10 mg benazepril QD x 24 weeks. 10 mg benazepril QD and TCM placebo TID x 24 weeks MDRD study equation, TCM assessing sheets eGFR (mL/min/1.73 m2) (pre vs post): T1: 45.26±10.12 vs 48.46±15.90, p<0.05. T2: 44.68±9.82 vs 48.31±17.50, p<0.05. Yes 7.07{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; T1), 8.12{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; T2) 6 months
    24 h proteinuria (mg/24 h) (pre vs post): T1: 725.98 vs 990.00, p<0.05. T2: 590.00 vs 453.50, p<0.05 36.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria; T1), -21.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria; T2)
    Urinary albumin/creatinine (mg/gCr) (pre vs post): T2: 0.30 vs 0.22, p<0.05 -26.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (urinary albumin/creatinine; T2)
    Hb (g/L) (pre vs post): T1: 127.31±18.47 vs 129.57±21.82, p<0.05 17.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Hb; T1)
    Yu et al. (2017) [50] Renal function Acupuncture at Li4, ST36 and K13 acupoint QD x 3 months Sham acupuncture QD x 3 months NI SCr levels (mg/dL) (T vs C): baseline: 1.45 vs 1.67, p=0.1298. Post-intervention: 1.41 vs 1.65, p=0.0489. 3-month follow-up: 1.32 vs 1.81, p=0.0467 Yes -2.76{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre vs post), -9.00{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre- vs 3 months follow-up) 6 months
    eGFR (mL/min/1.73m2) (T vs C): Baseline: 51.85 vs 42.50, p=0.0855. Post-intervention: 54.50 vs 43.60, p=0.0470. 3-month follow-up: 59.90 vs 40.80, p=0.0191 5.11{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; pre vs post), 15.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; pre-intervention vs 3 months follow-up)
    hs-CRP (mg/dL) (T vs C): Baseline: 1.10 vs 0.79, p=0.4361. Post-intervention: 0.80 vs 0.90, p=0.8773 -27.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (hs-CRP pre vs post)
    Zhao et al. (2020) [52] Renal function Herbal granulec TID x 6 months Placebo granules x TID 6 months Dye-binding method, Cerebrospinal fluid protein test kit, Determiner L CRE kit SCr (μmol/L) (pre vs weeks 16, 20 and 24): 148.42±35.90 vs 130.19±29.79, 130.08±30.57, 130.78±32.55, p<0.05 Yes -12.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre vs 16 weeks), -12.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre vs 20 weeks), -11.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre vs 24 weeks) 6 months
    Xiang et al. (2016) [47] Renal function QDDHG tablets BID and ARB (minimum dosage) x 12 weeks ARB tablets (minimum dosage) Guidelines for clinical research of Chinese medicine Albumin (mg/24h) (within treatment group, baseline vs 4 vs 8 vs 12 week): 85.30 (66.00, 176.30) vs 61.50 (49.00, 110.20), p<0.05 vs 51.00 (37.00, 90.00), p<0.05 vs 41.40 (29.00, 68.00), p<0.05 Yes -27.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Albumin; 4 weeks), -40.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Albumin; 8 weeks), -43.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Albumin; 12 weeks) 3 months
    Proteinuria (g/24h) (within treatment group, baseline vs 4 vs 8 vs 12 week): 0.20 (0.10, 0.30) vs 0.10 (0.10, 0.20), p<0.05 vs 0.10 (0.10, 0.20), p<0.05 vs 0.10 (0.10, 0.20), p<0.05 -50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Proteinuria; 4, 8, 12 weeks)
    Albumin/creatinine (mg/mol) (within treatment group, baseline vs 4 vs 8 vs 12 week): 20.70 (11.00, 30.50) vs 16.30 (8.10, 25.00), p<0.05 vs 15.00 (7.20, 20.60), p<0.05 vs 10.10 (5.60, 17.00), p<0.05 -21.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (albumin/creatinine; 4 weeks), -27.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (albumin/creatinine; 8 weeks), -51.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (albumin/creatinine; 12 weeks)
    Xu et al. (2016) [49] Renal function 500 mg GS-Rb1 (ginseng extract) QD x 6 months  Placebo tablets QD x 6 months ELISA Creatinine and urea level (T vs C): 6 months, p<0.01. 12 months, p<0.01 Yes 12 months
    Oxidative stress markers (T vs C): 6 months, p<0.01. 12 months, p<0.05
    TNF-a level (T vs C): 6 months, p<0.05
    Chen et al. (2013) [37] Proteinuria 9.6 g of Shenqi particle TID x 48 weeks Routine care MDRD study equation Proteinuria (g/d) (pre vs post): 5.34±2.74 vs 2.04±2.15, p<0.001 Yes -61.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria) 12 months
    eGFR (mL/min/1.73 m2) (pre vs post): 84.6±27.0 vs 100.7±37.5, p=0.001 19.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR)
    Ge et al. (2013) [39] Proteinuria 40 mg TwHF TID x 3 months, 20 mg TwHF TID x 3 months. 160 mg valsartan capsules QD x 6 months Trichloroacetic acid method, Jaffe reaction, MDRD study equation, high-performance liquid chromatography Urinary protein (g/24 h) (pre vs 1 month, pre vs 3 months, pre vs 6 months): 4.99±2.25 vs 3.23±2.57, p<0.01. 4.99±2.25 vs 2.83±1.57, p<0.01. 4.99±2.25 vs 2.99±1.81, p<0.01 Yes -35.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (urinary protein; 1 months), -43.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (urinary protein; 3 months), -40.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (urinary protein; 6 months) 6 months
    eGFR (mL/min/1.73 m2) (pre vs 6 months): 43.07±21.65 vs 38.71±23.66, p<0.05 -10.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; 6 months)
    Li et al. (2020) [42] Proteinuria Huangkui capsule TID x 12 months Losartan potassium tablet QD and placebo capsules TIW x 12 months NI Proteinuria (mg/24 h) (pre vs post): 1238.9±667.4 vs 1008.8±1104.7, p<0.001 Yes -18.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria) 12 months
    Zhang et al. (2014) [51] Proteinuria T1: Huangkui capsule TID x 6 months. T2: Huangkui capsule TID and Losartan potassium tablet QD x 6 months. Losartan tablet potassium QD x 6 months Biuret method, sarcosine oxidase assay Proteinuria within T1 (pre vs 12 vs 24 weeks): 1045±420 vs 762±533, p<0.001 vs 537±409, p<0.001 Yes T1: -27.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pre vs 12 weeks), -48.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pre vs 24 weeks) 6 months
    Proteinuria within T2 (pre vs 12 vs 24 weeks): 1073±439 vs 783±658, p<0.001 vs 529±509, p<0.001. T2: -27.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pre vs 12 weeks), -50.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pre vs 24 weeks).
    Xiong et al. (2020) [48] Proteinuria 60 mg TWHF and 160 mg valsartan QD x 24 weeks 160 valsartan QD x 24 weeks CKD-EPI equation Proteinuria (g/24 h) (T vs C, PP analysis): 3.16±0.62 vs 4.28±0.85, p<0.001 Yes PP: -26.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria)  6 months
    Serum albumin (g/L) (T vs C, PP analysis): 37.65±4.31 vs 33.59±4.56, p<0.001 PP: 12.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (serum albumin)
    Proteinuria (g/24 h) (T vs C, ITT analysis): 3.36±0.83 vs 4.52±1.06; p<0.001 ITT: -25.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria)
    Serum albumin (g/L) (T vs C, ITT analysis): 36.91±4.42 vs 34.67±4.75, p=0.008 ITT: 6.46{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (serum albumin)
    Che-yi et al. (2005) [36] Uremic pruritus Acupuncture at Quchi (L11) acupoint TIW x 1 month Sham acupuncture TIW x 1 month Validated questionnaire Pruritus scores (pre vs post vs 3 months follow-up): 38.2±4.8 vs 17.3±5.5 vs 16.5±4.9, p<0.001 Yes -54.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus scores; pre- vs post-intervention), -56.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus scores; pre-intervention vs 3 months follow-up) 3 months
    Gao et al. (2002) [38] Uremic pruritus Acupuncture at Quchi (L11) and Zusanli (ST 36) acupoint BIW x 1 month Sham acupuncture BIW x 1 month NI Number of patients (complete alleviation vs improvement vs no effect): 24 (70.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) vs 9 (26.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) vs 1 (2.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Yes 3 months
    Nahidi et al. (2018) [7] Uremic pruritus 30 minutes of acupuncture, for six weeks, at the following acupoints: Sp6, Sp10, Lv3, Li4, Li11. 30 minutes of sham acupuncture, for 6 weeks. VAS Pruritus scores (pre vs post): 9.87±0.35 vs 3.93±2.85, p<0.001 Yes -60.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus scores) 6 weeks
    Ono et al. (2015) [3] Fatigue, insomnia, itchiness, and pain Acupuncture QIW x 2 months Routine care VAS, EQ-5D Headache score (pre vs post): 17.1±26.1 vs 6.2±13.5, p<0.05. Yes -63.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (headache score)  3 months
    Blurred vision score (pre vs post): 33.4±32.7 vs 17.0±22.2, p<0.05. -49.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (blurred vision score) 
    Dizziness score (pre vs post): 13.0±21.4 vs 1.4±6.3, p<0.05. -89.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (dizziness score) 
    Ear buzzing (pre vs post): 17.9±27.2 vs 8.0±14.7, p<0.05 -55.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (ear buzzing)
    Cervical pain (pre vs post): 37.7±39.1 vs 25.3±29.7, p<0.05 -32.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (cervical pain) 
    Stiff shoulders (pre vs post): 29.9±28.6 vs 12.5±21.6, p<0.05 -58.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (stiff shoulders) 
    Back pain (pre vs post): 38.5±33.7 vs 9.3±18.1, p<0.05 -58.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (back pain)
    Lower limb pain (pre vs post): 29.4±36.4 vs 17.1±23.3, p<0.05 -41.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (lower limb pain) 
    Numbness in upper limb (pre vs post): 18.9±30.4 vs 4.0±29.5, p<0.05 -78.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (numbness in upper limb) 
    Numbness in lower limb (pre vs post): 21.9±34.9 vs 11.0±26.2, p<0.05 -49.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (numbness in lower limb) 
    Itchiness (pre vs post): 38.7±40.7 vs 29.3±31.5, p<0.05 -24.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (itchiness)
    Difficulty in sleeping (pre vs post): 34.8±36.9 vs 12.8±22.5, p<0.05 -63.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (difficulty in sleeping)
    Utility in treatment group (pre vs post): 0.66±0.15 vs 0.76±0.17, p<0.05 15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (utility)
    Su et al. (2009) [44] QoL Infrared stimulation of Qihai (RN6), Kuamyuan (RN4) and Chungchi (RN3) TIW x 3 months Heat pad therapy to acupoints TIW x 3 months Heart rate variability analyser, WHOQOL-BREF questionnaire LF activity (pre vs post): 49.99±79.08 vs 131.71±214.36, p=0.01 Yes 163{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (LF activity) 3 months
    Fatigue index (pre vs post): 133.90±20.43 vs 121.71±32.68, p=0.02 -9.10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (fatigue index)
    Psychological domain (pre vs post): 18.16±4.30 vs 19.39±0.72, p=0.02 6.77{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (psychological domain)
    Environmental domain (pre vs post): 29.87±4.04 vs 32.00±4.85, p=0.00. 7.13{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (environmental)
    Wang et al. (2019) [45] Wnt/β-catenin signaling pathway Qingshen granules TID x 3 months Placebo granules TID x 3 months ELISA Effective rates of TCM symptom (T vs C): 80{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} vs 60{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, p=0.024 Yes 3 months
    eGFR (mL/min) (T vs C): 15.9±3.2 vs 14.0±4.0, p=0.019 17.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR)
    HIF-1𝛼 (ng/mL) (T vs C): 0.66±0.16 vs 1.39±0.17, p≤0.001 -61.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (HIF-1𝛼)
    Wnt1 (pg/mL) (T vs C): 314.2±85.8 vs 382.8±85.3, p=0.001 -16.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Wnt1)
    𝛽-catenin (pg/mL) (T vs C): 416.5±13.6 vs 462.1±15.1, p ≤0.001 -10.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (𝛽-catenin)
    𝛼-SMA (KU/L) (T vs C): 20.5±3.1 vs 23.5±4.1, p≤0.001 -20.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (𝛼-SMA)
    E-cadherin (ng/mL) (T vs C): 2166.9±398.6 vs 2370.7±468.0, p=0.039 -15.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (E-cadherin)
    Wang et al. (2020) [46] Immune function Qingshen granules TID x 3 months Routine care Flow cytometry, ELISA CD4+/CD8+ T cell (pre vs post): 1.98±0.86 vs 1.58±0.72, p<0.05. Yes -20.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (CD4+/CD8+ T cell) 3 months
    Th17 cell (pre vs post): 2.51±1.05 vs 1.70±0.83, p<0.01. -32.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Th17)
    NF-κB p65 (pre vs post): 36.84±12.96 vs 24.86±1.97, p<0.05 -32.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (NF-κB p65)
    IL-17 (pre vs post): 28.62±13.53 vs 19.78±12.25, p<0.05 -30.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-17)
    IL-6 (pre vs post): 77.13±20.54 vs 58.42±18.25, p<0.05 -24.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-6)
    TNF-α (pre vs post): 110.34±23.76 vs 75.49±22.80, p<0.01 -31.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TNF-α)
    TRAF6 (pre vs post): 4.94±1.82 vs 2.85±1.53, p<0.01 -42.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TRAF6)
    FN (pre vs post): 93.42±20.36 vs 62.86±19.35, p<0.01 -32.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (FN)
    Col-IV (pre vs post): 36.85±14.58 vs 24.36±13.36, p<0.01 -33.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Col-IV)
    Total effective rate (T vs C): 79.41{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} vs 67.12{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, p<0.05.
    Li et al. (2009) [40] Vascular endothelial function TBN tablets (gingko extract) TID x 8 weeks Routine care Chemical colorimeter, Radioimmunoassay, ELISA, Siemens Sequoia 512 color Doppler ultrasonography UAER (μg/min) (pre vs post): 153.30±63.28 vs 85.15±36.82, p<0.01 Yes -44.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (UAER) 3 months
    SCr (μmol/L) (pre vs post): 120.76±17.83 vs 105.67±18.13, p<0.01 -12.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr)
    NO (μmol/L) (pre vs post): 50.16±24.64 vs 70.65±28.71, p<0.01 40.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (NO)
    vWF ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (pre vs post): 182.05±64.13 vs 128.56±48.98, p<0.01 -29.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (vWF)
    BAID responsive change ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (pre vs post): 4.91±2.31 vs 6.78±3.89, p<0.01 38.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (BAID responsive change)
    Ayurveda (n=6)
    Alam et al. (2020) [53] Renal function Sativa oil QD and alpha-keto amino acid tablets TID x 3 months Alpha-keto amino acid tablets TID x 3 months Hemogram, renal function test, serum electrolyte test Hb{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (g/dL) (pre vs post): 8.84±1.31 vs 10.24±1.10, p<0.001 Yes 15.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Hb{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) 3 months
    24-h TUV (mL/day) (pre vs post): 1250.69±303.74 vs 1660.14±258.78, p<0.001 32.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TUV)
    eGFR (mL/min) (pre vs post): 22.71±7.28 vs 42.42±17.38, p<0.001 86.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR)
    Fallahzadeh et al. (2012) [54] Renal function 140 mg silymarin tablet QD x 3 months Placebo tablet QD x 3 months Jaffé method, ELISA MDA assay, MDRD study equation, nephelometry, high-performance liquid chromatography, mercury sphygmomanometer Urinary TNF-α (pg/mg) (change from baseline): -3.45 (-5.44 to -1.46), p<0.05 Yes 2 months
    Urinary MDA (nmol/mg) (change from baseline): -1.5 (-2.87 to -0.13, p<0.05
    Serum MDA (μmol/L) (change from baseline): -3.43 (-6.02 to -0.83), p<0.05
    Hoseini et al. (2019) [55] Renal function Camel milk BID x 3 months Routine care MDRD eGFR (pre vs post): 26.9±7.39 vs 31.45±8.99, p=0.001 Yes 16.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR) 3 months
    SCr levels (pre vs post): 2.58±0.71 vs 2.2±0.48, p=0.01 -14.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr)
    BUN (pre vs post): 60.31±22.61 vs 44.38±14.29, p=0.0001 -26.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (BUN)
    Khajehdehi et al. (2011) [56] Renal function 140 mg silymarin TID x 3 months Placebo tablet TID x 3 months ELISA Proteinuria (mg/24h) (pre vs post, patients with type 2 diabetic nephropathy): 4328.7±3038.2 vs 2354.7±1800.1, p=0.001 Yes -45.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria) 2 months
    IL-8 (pg/mL) (pre vs post, patients with type 2 diabetic nephropathy): 99.1±97.9 vs 43.6±55.0, p=0.002 -56.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-8)
    TGF-β (pg/mL) (pre vs post, patients with overt type 2 diabetic nephropathy): 522.3±189.2 vs 397.3±55.2, p=0.006 -23.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TGB-β)
    IL-8 (pg/mL) (pre vs post, patients with overt type 2 diabetic nephropathy): 41.4±50.3 vs 30.6±75.2, p=0.02 -26.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-8)
    Makhlough et al. (2010) [57] Uremic pruritus 0.03{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} capsaicin ointment QID x 4 weeks Placebo ointment QID x 4 weeks Uremic pruritus scoring questionnaire by Duo Pruritus score (T vs C): 2.5±2.5 vs 7.2±5.5, p<0.05 Yes -84.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score)  
    Pingali et al. (2020) [58] Hyperuricemia T1:500 mg of beleric capsule taken QD. T2: 1000 mg of beleric capsule taken QD 40 mg of Febuxostat taken QD Jaffe method, MDRD Study equation, Salbutamol challenge test, Ellman’s method, Chrono-log light transmittance aggregometry, Spectrometry, Colorimetric detection with Griess reagents SCr (pre vs post): group B: 1.86±0.32 vs 1.64±0.29, p≤0.005. Group C: 2.06±0.26 vs 1.56±0.24, p≤0.0001 Yes -11.70{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±9.00 (SCr, group B), -24.42{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±8.14 (SCr, group C). 6 months
    eGFR (pre vs post): group B: 39.13±6.57 vs 45.96±11.14, p≤0.005. Group C: 34.78±5.34 vs 48.93±11.46, p≤0.0001 16.96{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±14.87 (eGFR, group B), 40.39{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±20.98 (eGFR, group C)
    Serum uric acid (pre vs post): Group B:8.10±0.67 vs 6.46±0.34, p≤0.0001. Group C: 8.54±0.64 vs 5.63±0.37, p≤0.0001 19.84{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±6.43 (serum uric acid, group B), 33.88{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±4.95 (serum uric acid, group C)
    Naturopathy (n=5)
    Khan et al. (2014) [60] Malnutrition Alpha-keto amino acid tablets TID x 3 months Placebo tablets TID x 3 months Blood tests Hb{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (g/dL) (T vs C): 9.39±0.87 vs 8.91±1.48, p<0.05 Yes 19.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Hb{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) 3 months
    FBG (mg/dL) (T vs C): 104.00±8.46 vs 113.78±14.31, p<0.001 -20.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (FBG)
    Blood urea (mg/dL) (T vs C): 66.07±19.29 vs 79.78±24.79, p<0.001 -38.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (blood urea)
    SCr (mg/dL) (T vs C): 2.83±1.10 vs 3.33±1.37, p<0.05 -39.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr)
    24 h TUP (g/day) (T vs C): 2.06±0.61 vs 2.43±0.97, p<0.01 -38.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TUP)
    24 Hour TUV (mL/day) (T vs C): 1943.23±204.1 vs 1736.76±176.04, p<0.001 33.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TUV)
    GFR (mL/min) (T vs C): 29.4±3.68 vs 23.3±1.63, p<0.001 49.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (GFR)
    Prakash et al. (2004) [61] Malnutrition Keto amino acid tablets QD x 9 months Placebo tablets QD x 9 months 99mTc-DTPA plasma sample method GFR (mL/min/ 1.73 m2) (pre vs post within C): 28.6±17.6 vs 22.5±15.9, p=0.015. Progress of renal failure prevented. 9 months
    Serum total proteins (g{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (pre vs post within C): 7.04±0.66 vs 6.56±0.83, p=0.038
    Mid-arm circumference (cm) (pre vs post within C): 28.0±4.4 vs 27.3±4.8, p=0.048
    Sedaghattalab et al. (2021) [62] Inflammation Watercress extract QD x 1 month Placebo extract QD x 1 month Blood tests, TBA reaction assay, Colorimetric kits, Spectrophotometer BUN (mg/dL) (pre vs post): 40.6±11.2 vs 34.6±15.1, p<0.04. Yes -14.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (BUN) 1 month
    Calcium (mg/dL) (pre vs post): 8.8±1.32 vs 10.4±2, p<0.001 18.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (calcium)
    Total oxidant status (μM) (pre vs post): 11.3±3.3 vs 6.9±2.4, p<0.001 -38.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (total oxidant status)
    Sulfhydryl protein (mmol/L) (pre vs post): 13.1±5.3 vs 7.4±4.3, p<0.001 -43.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (sulfhydryl protein)
    MDA (mmol/L) (pre vs post): 1.6±0.13 vs 0.42±0.27, p<0.001 -73.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (MDA)
    Superoxide dismutase (U/mL) (pre vs post): 29.3±6.3 vs 37.1±8.4, p<0.001 26.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (superoxide dismutase)
    Zare et al. (2019) [63] Inflammation Garlic extract tablets TIW x 2 months Placebo tablets TIW x 2 months Human homocysteine kits, ELISA IL-6 (pg/mL) (pre vs post): 2.2 (0.8, 6.4) vs 0.7 (0.6, 1.2), p<0.001 Yes -68.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-6) 2 months
    CRP (mg/L) (pre vs post): 13.0 (5.0, 14.0) vs 2.0 (1.0, 9.0), p<0.001 -84.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (CRP)
    ESR (mm) (pre vs post): 50.7±28.5 vs 35.4±21.7, p=0.021. -30.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (ESR)
    Boldaji et al. (2019) [59] Hypertension, stress, and inflammation Pomegranate juice TIW x 2 months Routine care Mini nutritional assessment MDA (μmol L-1) (pre vs post): 0.88±0.01vs 0.77±0.01, p<0.001 Yes -12.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (MDA) 2 months
    Total antioxidant capacity (mmol L-1) (pre vs post): 0.40±0.08vs 0.49±0.11, p<0.001 22.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (total antioxidant capacity)
    IL-6 (ng L-1) (pre vs post): 3.00±1.48 vs 2.09±1.25, p<0.0001 -30.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-6)
    Homeopathy (n=2)
    Cavalcanti et al. (2003) [16] Uremic pruritus Homeopathic verum medicationd administered Placebo medication administered Validated scale Pruritus score (pre vs 15 vs 30 vs 45 vs 60 days): 65±25 vs 46±29, p=0.002 vs 41±30, p=0.002 vs 42±29, p=0.002 vs 38±33, p=0.004 Yes -29.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score, pre vs 15 days), -36.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score, pre vs 30 days), -35.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score, pre vs 45 days), -41.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score, pre vs 60 days) 60 days
    Silveira et al. (2019) [64] Renal function Brazilian green propolis pills BID x 3 months Placebo pills BID x 3 months Immunoturbidimetry, ELISA Proteinuria (mg/24 h) (T vs C, baseline vs 12 months): 695 (95{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} CI, 483 to 999) vs. 1403 (95{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} CI, 1031 to 1909); p=0.004 Yes -27.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria) 12 months

    Tools used for outcomes assessments of symptoms during interventions are as follows: the most frequently utilized tools were the abbreviated version of the World Health Organization Quality of Life-100 Questionnaire (n=2) and visual analog scale (n=2).

    Risk of bias within studies: Out of all included studies, 14 (42.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) studies were assessed to be of “low” risk of bias, nine (27.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and 10 (30.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) studies were scored as “some concerns” and “high” risk of bias, respectively.

    Results of Individual Studies

    Traditional Chinese medicine: The most commonly utilized interventions in the studies were herbal treatments (n=14, 70{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [17, 37-43, 45-49, 51, 52] followed by acupuncture (n=6, 30{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [3,7,36,38,44,50]. For acupuncture treatment, five studies used conventional acupuncture [3,7,36,38,50] while one study used infrared stimulation of acupoints [44]. The common acupoints administered during conventional acupuncture treatment were Li11 (n=3, 60{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), ST36 (n=2, 20{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), and Li4 (n=2, 20{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). The frequency of acupuncture ranged from once a week to once a day, whereas the duration of studies lasted between six weeks to six months. Uremic pruritus (n=3, 60{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) was the most commonly studied indication, with reductions in pruritus score observed between 54.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 60.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} [7,36,38]. Infrared stimulation was used on RN6, RN4, and RN3 thrice a week for three months [44]. The indication studied was quality of life (QoL). According to QoL scores that were evaluated using the EQ-5D questionnaire, utility increased by 15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}.

    Herbal treatments include six single-herb (n=6, 42.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [39-42,48,49,51] and eight multi-herbs formula granules (n=8, 57.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [17,37,41,43,45-47,52]. Common single-herb treatments used are Huangkui (n=2, 33.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and TWHF (n=2, 33.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). The frequency of treatment was once to three times a day, for two to 12 months. Proteinuria was the most studied indication (n=4, 66.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), where the various treatments reduced proteinuria between 27.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 61.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} [39,42,48,51]. Common herbs used in the multi-herb formula granules studies included Huang Qi (n=6, 75{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), Danggui (n=4, 50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), Salvia miltiorrhiza (n=3, 37.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), and Poria (n=3, 37.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). The most commonly studied indication was improvement in renal function (n=5, 62.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [17,41,43,47,52]. Serum creatinine decreased (2.76-12.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and eGFR increased (7.07-15.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) across the various treatments.

    Ayurveda: The included studies evaluated both plant-based (n=3, 50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [53,54,56] and animal-based (n=3, 50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) treatments [55,57,58]. The most common treatment studied was plant-based silymarin tablets (n=2, 33.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) while that for clinical indication was improvement in renal function (n=4, 66.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [53-56]. The eGFR increased between 16.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 86.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} across the various treatments [53-56].

    Naturopathy: Keto amino acids were the most studied naturopathic treatment (n=2, 40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). Common indications studied included anemia and glucose control, where hemoglobin and fasting blood glucose levels in subjects improved by 19.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 20.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, respectively [60,61]. The use of watercress and garlic extract was also studied for inflammation, where the total oxidant status and IL-6 levels were shown to improve by 38.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 68.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, respectively.

    Homeopathy: Homeopathic verum was studied for relief of uremic pruritus with improvement in pruritus score between 29.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 41.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} [16]. For Brazilian green propolis pills, it was studied for proteinuria where a 27.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} reduction in proteinuria was noted [64].

    Safety Profile of AMS Interventions

    The adverse events reported by all included studies are shown in Table 3. Adverse events reported were of grade 1 (n=13, 39.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), grade 2 (n=8, 24.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), and grade 3 (n=6, 18.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) severity. There were no life-threatening consequences or death related to adverse effects (grades 4 and 5) reported.

    Study (year) N (T) Treatment Reported adverse effects based on Common Terminology Criteria for Adverse Effects (CTCAE) v5.0a,b,c Onset of adverse effects (if available) Management and outcomes of patients
    Grade 1 ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Grade 2 ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Grade 3 ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Traditional Chinese medicine (n=19)
    Chenet al. (2013) [37] 95 9.6 g of Shenqi particle TID x 48 weeks NI Interstitial pneumonia (n=1, 1.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Lung infection (n=5, 5.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); liver injury (n=3, 3.15{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Geet al. (2013) [39] 34 40 mg Tripterygium Wilfordii Hook F TID x 3 months Vomiting (n=13, 38.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Hyperkalaemia (n=8, 23.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); Leukopenia (n=1, 2.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); Photosensitive dermatitis (n=3, 8.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NI Patient with decreased white blood cell withdrawn from the study
    Liet al. (2020) [42] 735 Huangkui capsule TID x 12 months NA NA Upper respiratory tract infections (n=21, 2.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Zhanget al. (2014) [51] T1:133 T2:136 T1: Huangkui capsule TID x 6 months T2: Huangkui capsule TID and Losartan potassium tablet QD x 6 months  Elevated cholesterol (T1: n=5, 3.76{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=4, 2.94{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Upper respiratory tract infections (T1: n=4, 3.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=4, 2.94{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Liver injury (T1: n=3, 2.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Xionget al. (2020) [48] 62 60 mg Tripterygium Wilfordii Hook F and 160 mg valsartan QD x 24 weeks Itchy skin (n=4, 6.45{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); nausea (n=3.22{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); rash (n=1, 1.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA Liver dysfunction (n=12, 19.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); leukopenia (n=1, 1.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Liet al. (2015) [41] 122 8 g Tangshen Formula granules and angiotensin receptor blockers BID x 24 weeks NA Anaemia (n=2) Acute myocardial infarction (n=5) NI NI
    Maet al. (2013) [43] 25 150 mL zishentongluo solution BID x 3 months NA NA NA NA NA
    Wanget al. (2012) [17] T1:192 T2:191 T1: TCM granules BID x 24 weeks T2: TCM granules BID and 10 mg benazepril QD x 24 weeks Dry cough (T2: n=2, 1.04{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); Gastrointestinal symptoms (T1: n=7, 3.64{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=3, 1.57{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Anaemia (T1: n=7, 3.64{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=6, 3.14{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Liver injury (T1: n=2, 1.04{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=5, 2.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); hyperkalaemia (T1 n=7, 3.64{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2 n=18, 9.42{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Yuet al. (2017) [50] 28 Acupuncture at Li4, ST36 and K13 acupoint QD x 3 months Mild pain, bleeding and bruising in some patients  NA NA NI Symptoms resolved spontaneously without any treatment
    Zhaoet al. (2020) [52] 171 Herbal granules TID x 6 months Mild abnormal liver function test (n=5, 2.92{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); Mild discomfort (n=2, 1.17{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA   NI NI
    Xianget al. (2016) [47] 51 QDDHGb tablets BID x 12 weeks Insomnia (n=1, 1.96{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NI NI
    Xuet al. (2016) [49] 91 500 mg GS-Rb1 (ginseng extract) QD x 6 months  NA NA NA NI NI
    Che-yiet al. (2005) [36] 20 Acupuncture at Quchi (L11) acupoint TIW x 1 month Elbow soreness (n=2; 10.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NI Symptoms resolved spontaneously after 1 day.
    Gaoet al. (2002) [38] 34 Acupuncture at Quchi (L11) and Zusanli (ST 36) acupoint BIW x 1 month NA NA NA NA NA
    Nahidiet al. (2018) [7] 15 Acupuncture at various acupoints TIW x 6 weeks NA NA NA NA NA
    Onoet al. (2015) [3] 23 Acupuncture QIW x 2 months NA NA NA NA NA
    Suet al. (2009) [44] 31 Infrared stimulation of Qihai (RN6), Kuamyuan (RN4) and Chungchi (RN3) TIW x 3 months NA NA NA NA NA
    Wanget al. (2019) [45] 41 Qingshen granules TID x 3 months NA NA NA NA NA
    Wanget al. (2020) [46] 136 Qingshen granules TID x 3 months NA NA NA NA NA
    Liet al. (2009) [40] 32 Tianbaoning tablets (gingko extract) TID x 8 weeks NA NA NA NA NA
    Ayurveda (n=6)
    Alamet al. (2020) [53] 70 Sativa oil QD and alpha-keto amino acid tablets TID x 3 months NA NA NA NA NA
    Fallahzadehet al. (2012) [54] 30 140 mg silymarin tablet QD x 3 months Nausea and vomiting (n=3, 10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); headache (n=2,6.67{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NI NI
    Hoseiniet al. (2019) [55] 22 Camel milk BID x 3 months NA Abdominal pain (n=1, 4.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NI NI
    Khajehdehiet al. (2011) [56] 28 140 mg silymarin TID x 3 months NA NA NA NA NA
    Makhlough et al. (2010) [57] 17 0.03{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} capsaicin ointment QID x 4 weeks NA Severe skin burning (n=1, 2.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NI NI
    Pingaliet al. (2020) [58] 18 1000 mg of beleric capsule taken QD Mild gastrointestinal intolerance (n=2, 11.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NA NA
    Naturopathy (n=5)
    Khanet al. (2014) [60] 80 Alpha-keto amino acid tablets TID x 3 months Nausea (n=5, 6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); diarrhoea (n=5, 6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NA NA
    Prakashet al. (2004) [61] 21 Keto amino acid tablets QD x 9 months NA NA NA NI NI
    Sedaghattalabet al. (2021) [62] 22 Watercress extract QD x 1 month NA NA NA NA NA
    Zareet al. (2019) [63] 19 Garlic extract tablets TIW x 2 months NA NA NA NI NI
    Boldajiet al. (2019) [59] 22 Pomegranate juice TIW x 2 months Stomach discomfort (n=1, 4.54{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NI NI
    Homeopathy (n=2)
    Cavalcantiet al. (2003) [16] 11 Homeopathic verum medicationc administered NA NA NA NA NA
    Silveiraet al. (2019) [64] 18 Brazilian green propolis pills BID x 3 months NA NA NA NA NA

    Adverse effects associated with traditional Chinese medicine: the use of acupuncture is associated with mild pain, bleeding, bruising, and elbow soreness (grade 1) [36,40]. These symptoms resolved spontaneously without additional treatment. For single-herb treatments, TWHF treatment was associated with vomiting (38.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1), itchy skin (6.45{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1), nausea (3.22{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1), and rash (1.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1) [39,48]. Grade 2 adverse events associated with its use included hyperkalemia (23.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), leukopenia (2.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), and photosensitive dermatitis (8.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), while grade 3 adverse effects included liver dysfunction (19.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and severe leukopenia (1.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). Subjects who developed leukopenia were withdrawn from the study.

    For Huangkui treatment, adverse effects observed included elevated cholesterol (2.94-3.76{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (grade 1), upper respiratory tract infection (2.94-3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (grade 2 and grade 3), and liver injury (2.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (grade 3) [42,51]. The use of Shenqi particles was associated with interstitial pneumonia (1.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 2), lung infection (5.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 3), and liver injury (3.15{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 3) [37]. Anemia (grade 2) and acute myocardial infarction (grade 3) were observed for subjects using Tangshen formula granules [41]. The use of QDDHG tablets was associated with insomnia (1.96{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1) [47].

    Adverse effects associated with ayurveda: Silymarin treatment was associated with nausea and vomiting (10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), as well as headache (6.67{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [54,56]. Beleric capsule treatment was associated with mild gastrointestinal intolerance (11.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [58]. Adverse effects from both studies were of grade 1 severity. Abdominal pain (4.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 2) was observed with the treatment of camel milk [55].

    Adverse effects associated with naturopathy: All adverse effects reported for naturopathy treatments are of grade 1 severity (Table 3). They include nausea (6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and diarrhea (6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) with the use of alpha-keto amino acid [60], as well as stomach discomfort (4.54{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) with the use of pomegranate juice [59].

    Adverse effects associated with homeopathy: No adverse effects were reported with the use of homeopathy (Table 3).

    Summary of Efficacy and Safety Profile of AMS Interventions

    Table 4 shows a summary related to the efficacy and safety profiles of AMS interventions.

    Type of AMS Common doses and treatment regimens and duration of therapy Indications Percentage reduction in CKD symptoms (if available) Adverse effects reported ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    TCM (n=20) [3,7,17,36-52] Herbal Renal function 2.76{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 51.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} Elbow soreness (10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); liver injury and dysfunction (1.04-19.40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); dry cough, pneumonia, and upper respiratory infections (1.04-5.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); hyperkalemia (3.64-23.50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); vomiting (38.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); leukopenia and anemia (1.61-2.90{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); photosensitive dermatitis, itchy skin, and rash (1.65-8.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); gastrointestinal symptoms, nausea, and vomiting (1.57-38.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); insomnia (1.96{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Herbal granules TID x 6 months; QDDHG tabletsa BID x 12 weeks; 500 mg GS-Rb1 QD x 6 months; 8 g TSF granules and ARB BID x 24 weeks; 150 mL ZSTL solution BID x 3 months; TCM granules BID x 24 weeks
    Acupuncture
    Acupuncture at Li4, ST36 and K13 acupoint QD x 3 months
    Herbal Proteinuria -61.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to -18.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    9.6 g of Shenqi particle TID x 48 weeks; 40 mg TWHF TID x 3 months followed by 20 mg TWHF TID x 3 months; Huangkui capsule TID x 12 months; 60 mg TWHF and 160 mg valsartan QD x 24 weeks
    Acupuncture Uremic pruritus -60.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to -54.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Acupuncture at Quchi (L11) acupoint TIW x 1 month; acupuncture at Quchi (L11) and Zusanli (ST 36) acupoint BIW x 1 month; acupuncture at various acupoints TIW x 6 weeks
    Acupuncture QIW x 2 months Fatigue, insomnia, itchiness, and pain -89.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Infrared stimulation of Qihai (RN6), Kuamyuan (RN4) and Chungchi (RN3) TIW x 3 months QoL -9.10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 163{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Qingshen granules TID x 3 months Wnt/β-catenin signaling pathway -61.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 17.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Qingshen granules TID x 3 months Immune function 42.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to -20.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    TBN tablets (gingko extract) TI x 8 weeks Vascular endothelial function 44.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 40.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ayurveda (n=6) [53-58] Plant-based Renal function -56.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 86.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} Nausea, vomiting, and headache (6.67-10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); abdominal pain (4.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) severe skin burning (2.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Sativa oil QD and alpha-keto amino acid tablets TID; 140 mg silymarin TID x 3 months; 140 mg silymarin tablet QD x 3 months
    Animal-based
    Camel milk BID x 3 months
    0.03{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} capsaicin ointment QID x 4 weeks Uremic pruritus -84.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    1000/500 mg of beleric capsule taken QD Hyperuricemia -24.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 40.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Naturopathy (n=5) [59-63] Alpha-keto amino acid tablets TID x 3 months; Keto amino acid tablets QD x 9 months Malnutrition 39.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 49.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} Nausea (6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); diarrhea (6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); stomach discomfort (4.45{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Watercress extract QD x 1 month; garlic extract tablets TIW x 2 months Inflammation -73.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 26.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Pomegranate juice TIW x 2 months Hypertension, stress, and inflammation -30.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 22.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Homeopathy (n=2) [16,64] Homeopathic verum medicationb administered x 60 days; Brazilian green propolis pills BD x 3 months Uremic pruritus -41.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to -29.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Renal function -27.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

    Discussion

    To the best of our knowledge, this is the first review that has summarized findings related to the therapeutic uses of AMS for CKD patients in RCTs. Among the four classes of AMS, TCM was the most studied class which has demonstrated efficacy in improving CKD-related symptoms and outcomes [3,7,36-52]. Among the TCM interventions evaluated, Huangkui, TWHF, and acupuncture have shown efficacy in reducing proteinuria and relieving uremic pruritus symptoms. The therapeutic basis of TCM for CKD is rooted in the restoration of vital energy and nourishment of blood, dispelling of heat and reduction of dampness, and regulation of Yin and Yang in the body [65]. In Western medicine, this is seen in a reduction in inflammation and oxidative stress, as well as boosting micro-circulation and enhancement of metabolism [52]. For example, Huangkui, also known as Abelmoschus manihot, reduces proteinuria by removing oxygen radicals, improving the circulation, and clearance of immune complexes as well as reducing inflammation and renal tubular epithelial injury [66]. It is also noted that triptolide, the key constituent of TWHF, suppresses the nuclear factor kappa b (NF-κB) signaling pathway and prevents the trigger of T lymphocytes and some inflammatory cytokines (TNF-α, IL-1β, IL-6, and IFN-γ), in addition to its podocyte-protective capabilities [67-70]. Notably, two of the included studies demonstrated that a combination of TCM and Western medicine, such as the intake of Huangkui capsule and losartan tablet to alleviate proteinuria, is more efficacious than taking TCM or Western medicine alone. This adds to existing evidence on potential applications of TCM alongside conventional medical therapy. Among patients on TWHF, regular checks of potassium and liver enzymes should be performed due to the risk of hyperkalemia and raised liver enzymes.

    With regards to the use of acupuncture, it results in the release of endogenous opiate-like substances that have been proposed to dull the peripheral and central perception of itching [71]. Stimulation of acupoints via far infrared (FIR) treatments has also been revealed to boost skin microcirculation, lessen emotional anxiety and promote excretion of waste products by improving the autonomic nervous system [44,72-76]. Enhanced circulation via a stronger autonomic nervous system is postulated to relieve CKD-related symptoms as the development of renal failure is attributed to poor circulation in the field of TCM [73,77]. Currently, renowned hospitals in the United States such as the Mayo Clinic and Duke University Medical Center have started providing acupuncture, along with other treatments. With growing evidence related to the efficacy and safety of TCM, there has been greater receptivity from medical doctors related to applications and use of TCM in clinical practice [78]. It is however important to note that TCM is not without any side effects. For example, the use of Huangkui should be cautioned in patients with hyperlipidemia or liver disease as its use has been associated with elevated lipid levels and liver injury. On the other hand, acupuncture appears to be relatively safe with mild side effects, such as elbow soreness. More studies related to TCM are required to further assess their long-term safety profile, and they should be prescribed with careful consideration of each patient’s health condition.

    For Ayurveda, silymarin was one of the most studied interventions which demonstrated efficacy in improving renal function. Ayurvedic therapies are derived predominantly from plants, animals, minerals, exercise, and lifestyle changes. They are believed to rejuvenate and remove toxins from one’s body. In conventional medicine, the therapeutic effects of ayurveda for CKD are ascribed to their anti-inflammatory and anti-oxidant properties. For instance, silymarin has shown efficacy in in vitro studies in attenuating inflammatory stress in renal tissue by suppressing the NF-κB signaling pathway and hence TNF production [79-85]. Other Ayurvedic treatments, such as the application of capsaicin ointment, were also found to alleviate uremic pruritus. Topical capsaicin, a natural alkaloid derived from red chili pepper, has been discovered to relieve uremic pruritus by binding specifically to type C sensory neurons and resulting in the release of substance P, as well as suppressing its synthesis, transport, and storage thereafter [57]. Relatively few side effects were observed for the Ayurvedic therapies discussed above. Despite the promising benefits associated with Ayurvedic treatments, it is currently less globally recognized as compared to TCM [86]. Further research is necessary to evaluate their efficacy and safety profile to improve their acceptance in clinical practice as adjunctive treatments, in particular for CKD patients.

    For naturopathy, its unique attribute lies in the reprioritization of the order of therapeutics, with increased emphasis on non-invasive treatments, such as lifestyle modifications and nutrition, over medical or surgical interventions. In this review, one of the more studied interventions is the use of ketoanalogues of essential amino acids (KAs). The addition of KAs to a low-protein diet has been shown to improve renal function and uremia. Notably, while lowering protein intake may improve renal function in CKD patients by altering immunologic events and reducing hypertrophy and hyperfiltration in the remaining nephrons, it may result in malnutrition [87-89]. However, the supplementation of KAs not only averts malnutrition by ensuring adequate consumption of amino acids but also alleviates uremia [61]. The absence of amino nitrogen in KAs allows them to become transaminated by taking nitrogen from non-essential amino acids and hence, reducing the production of urea via re-using the amino group [90,91]. Relatively few and mild adverse effects were observed for the included naturopathic therapies, rendering them attractive treatment options. Additionally, as naturopathic treatments are usually non-invasive, they can be easily combined with conventional medications. Of note, 28 health systems, hospitals, and cancer treatment centers in the United States currently have at least one licensed naturopathic physician at their premises [92]. With increasing research evaluating the efficacy and safety profile of naturopathic treatments, its role as potential adjunctive treatment for CKD patients is also likely to expand in the future.

    Lastly, homeopathy has also shown efficacy in improving CKD-related symptoms and outcomes. Homeopathy entails the therapeutic administration of substances derived from plants, minerals, or animals which produce effects that correspond to the clinical manifestation of diseases. In this review, the use of Brazilian green propolis pills and homeopathic verum medication were found to improve renal function and alleviate uremic pruritus, respectively. Brazilian green propolis was reported to improve renal function via a few mechanisms. Firstly, it decreases proteinuria via its ability to reduce urinary oxidative stress and macrophage infiltration into the kidneys [93]. Secondly, chrysin, a flavonoid in propolis has been shown to decrease podocyte apoptosis in patients with diabetic nephropathy and lessen glomerular injury [94]. Lastly, propolis has also been shown to decrease blood pressure via acetylcholine-induced vasodilation and from its antioxidant properties [93,95-97]. With regard to the safety of homeopathic treatment, no adverse effects were reported across included studies. However, the practice of homeopathy is relatively restricted, with 36{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of states in the United States requiring homeopathic practitioners to either be licensed Western medicine or Naturopathic practitioners [32]. Consequently, more research is necessitated to validate the efficacy and safety of homeopathic treatment as adjunctive therapy for CKD patients.

    Limitations

    The following limitations should be considered in conjunction with this review. Firstly, due to the clinical and methodological heterogeneity of the studies, meta-analyses were not performed. As the pool of evidence for AMS trials for CKD patients grows, subsequent reviews should consider conducting meta-analyses for the efficacy of AMS treatments for CKD patients. In addition, there could have been exclusion of potentially applicable studies even though an extensive search strategy was used. To prevent this, the references of included studies were also hand-searched as part of our search strategy. Another limitation of the study relates to the inclusion of only articles in English language. Researchers should consider the inclusion of studies in other languages such as Chinese and Tamil in future reviews. Finally, although results of the included studies were reported normalized Z scores, care should be taken when interpreting these values and comparing the efficacy of various AMS classes. This is due to considerable diversity in types of outcomes evaluated and comparator arms and tools adopted for evaluation of outcomes. Overall, it is hoped that with greater standardization of study outcomes for AMS therapies in future studies, these normalized Z scores can enable more purposeful comparisons of the efficacy of the different AMS classes.

  • QC Kinetix (Gainesville) Provides Regenerative Sports Medicine as an Alternative Treatment to Surgeries for Chronic Pain and Sports Injuries in FL

    QC Kinetix (Gainesville) Provides Regenerative Sports Medicine as an Alternative Treatment to Surgeries for Chronic Pain and Sports Injuries in FL

    Gainesville, FL – QC Kinetix (Gainesville) is delighted to announce that their sophisticated regenerative orthopedics is very powerful in supporting the body’s interior self-healing processes for those suffering from many human body suffering. These innovative treatments not only decrease ache but also relieve swelling and improve recovery time by supplying optimal assistance devoid of disagreeable aspect results. These therapies are even light ample to operate side-by-side with common treatments.

    “QC Kinetix is one particular of the leading suppliers of state-of-the-art regenerative orthopedics in Gainesville, FL. Our medical specialists focus on the musculoskeletal process, which is most handy in working with injuries from which athletes might put up with.” Commented the clinic’s spokesperson.

    In most cases, sports injuries are majorly associated with muscle mass tears, tendon, and ligament accidents, torn Achilles tendons, golfers elbow, tennis elbow, torn rotator cuff, and a lot of other sorts of agony. These problems if remaining untreated could trigger interior scarring of tissues which might direct to serious soreness. The discomfort can set undue tension on other parts of the musculoskeletal process major to pain in other spots.

    QC Kinetix (Gainesville) has a crew of expert health-related providers who offer you minimally invasive solutions that enhance perform and the high-quality of life with lengthy-lasting results. They supply the most suited answers and personalised concierge-level services and have so far dealt with hundreds of sufferers nationwide.

    QC Kinetix (Gainesville) Provides Regenerative Sports Medicine as an Alternative Treatment to Surgeries for Chronic Pain and Sports Injuries in FL

    The regenerative drugs Gainesville clinic brings together regenerative medicine and traditional treatment method procedures to treat numerous widespread sports activities accidents efficiently. The health-related companies have gained glowing testimonies from people who have successfully recovered following treatment method as can be observed on their internet site.

    All through the initially check out, their sports medication suppliers will completely study the injuries or bodily situation. In the system, they will explore targets, the things to do that led to the damage, and the patient’s total wellness. Based on the information gathered, the clients will receive personalized tips that accommodate unique requirements for their recovery. In the class of cure, sufferers will be re-evaluated, and changes will be made based mostly on their in general progress.

    QC Kinetix (Gainesville) has been offering the greatest high quality cure and care doable for its people considering the fact that 2022. Their regenerative sports activities medicine is made to support individuals mend and get back again to their energetic lifestyles in no time.

    The soreness command clinic is offered for inquiries from Monday – Thursday 8 am-6 pm, Friday – Sunday 8 am-4 pm. Sufferers looking for a put to get therapy in Gainesville, FL, are inspired to check out the clinic for expert consultation and personalised regenerative remedy ideas.

    To timetable a cost-free session and other inquiries, purchasers can call the clinic at (352) 400-4550. They can also go to their web site for a lot more information and facts on many clinic spots and any other facts about their solutions. QC Kinetix (Gainesville) is situated at 2555 SW 76th St, Suite 110, Gainesville, FL, 32608, United states.

    Media Get hold of

    Organization Identify
    QC Kinetix (Gainesville)
    Get hold of Identify
    Scott Hoots
    Telephone
    (352) 400-4550
    Address
    2555 SW 76th St, Suite 110
    City
    Gainesville
    Point out
    FL
    Postal Code
    32608
    State
    United States
    Web-site
    https://qckinetix.com/north-central-fl/gainesville/

  • Diagnosing and Treating Chronic Hypertension

    Diagnosing and Treating Chronic Hypertension

    Blood force is the pressure of blood versus the inner partitions of your arteries. This can transform throughout the working day and during your lifestyle. When your blood stress is perfectly above the regular healthful variety, it is called higher blood pressure or hypertension.

    At times you can have temporary spikes in blood stress, brought about by pressure or other aspects — including pregnancy. But when superior blood force results in being an ongoing condition, it’s considered persistent.

    There is no overcome for persistent hypertension, but there are medicines and life-style changes that can enable retain your blood pressure below command.

    No make a difference how hypertension commences, it’s critical to operate intently with a health practitioner and undertake a heart-wholesome way of life to avert continual hypertension from leading to serious and likely lifetime-threatening troubles.

    Blood stress is expressed by two numbers: the systolic tension or prime number on your blood strain studying, and the diastolic strain or base variety. The pressures are measured in millimeters (mm) of mercury (Hg).

    Systolic stress refers to the tension of blood in your arteries when your coronary heart contracts and pumps blood out to the entire body. Diastolic force is the force of blood versus the artery walls when your coronary heart is at relaxation.

    Substantial blood force is viewed as a systolic strain of 130 mm Hg or better or diastolic force of 80 mm Hg or larger. The Centers for Disease Management and Prevention (CDC) estimates that just about 50 {fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of all grown ups in the United States have large blood strain.

    Long-term hypertension is also named important hypertension or most important hypertension. It accounts for about 90{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of large blood strain scenarios, in accordance to the Planet Coronary heart Federation. There is commonly no acknowledged induce of major or long-term hypertension, nevertheless there is a extended checklist of chance components, including:

    • advancing age
    • diabetic issues
    • too much liquor consumption
    • spouse and children history
    • superior sodium use
    • weight problems
    • sedentary lifestyle
    • tobacco use

    Secondary hypertension, which accounts for far much less scenarios than chronic hypertension, is substantial blood stress caused by an additional health care issue, these as kidney sickness or thyroid issues. It is not regarded as long-term hypertension due to the fact managing the fundamental ailment can normally outcome in a return to usual blood pressure.

    It is very widespread for a expecting individual to create higher blood tension. The CDC experiences that hypertension happens in about 1 of each 12 to 17 pregnancies. But in pregnancy, continual hypertension will take on a somewhat distinct meaning and concern.

    Chronic hypertension differs from other significant blood tension issues related with being pregnant, together with preeclampsia and gestational hypertension. Continual hypertension means you had high blood stress prior to you grew to become expecting (or ahead of the pregnancy arrived at 20 weeks) and you proceed to have substantial blood pressure during the being pregnant and afterward.

    Preeclampsia is large blood tension that first develops in the course of pregnancy and suggests that there’s protein in your urine or there are other associated wellbeing problems right after 20 weeks. Gestational hypertension is also high blood stress that initial develops in the course of pregnancy, but is not accompanied by protein in the urine or other coronary heart or kidney challenges.

    Mainly because continual hypertension in pregnancy is these a typical occurrence, it has been an lively area of analysis for a prolonged time.

    For instance, a 2017 analyze suggests that a particular person who experienced gestational hypertension or preeclampsia may be extra inclined to create continual hypertension, however that hazard can be substantially reduced by maintaining a moderate bodyweight and following heart-balanced way of living behaviors.

    A 2022 study indicates that dealing with chronic hypertension in pregnant folks to a blood stress of under 140/90 mm Hg prospects to improved being pregnant outcomes, even between all those who have delicate persistent hypertension.

    Examine the lifestyle choices for lowering your blood strain when you are diagnosed with main or continual hypertension.

    Decreasing your blood force may be carried out with a mix of drugs and lifestyle variations created to support healthier coronary heart functionality. Between the behaviors that should really assist are:

    Food plan

    Being obese or obese is linked with superior blood force when getting rid of weight, and maintaining a moderate bodyweight is a vital to managing your blood stress.

    In addition, a diet regime superior in sodium and harmful fats is associated with superior blood force.

    To that conclude, health and fitness professionals endorse the Dietary Strategies to End Hypertension (Dash) diet program or the Mediterranean-type consuming program to help far better cardiovascular health. These meal plans emphasize fruits, veggies, entire grains, and lean proteins, when the Dash diet regime in particular focuses on minimizing sodium intake.

    A 2020 review indicates that adhering to the Sprint diet program is an particularly effective usually means of bringing your blood strain underneath manage.

    Physical exercise

    The American Heart Association recommends 150 minutes a week of average-depth physical exercise for superior heart health and fitness. Preferably, you want to physical exercise at least 30 to 40 minutes most times of the week.

    A brisk walk or comparable action not only helps support body weight administration, but it presents your cardiovascular system a fantastic exercise routine, which supports vascular wellness and blood tension command.

    Other ways

    Other life-style changes can make a massive change in decreasing blood force. Contemplate the pursuing variations for lower blood stress and much better overall wellness:

    • Get at the very least 7 to 8 hrs of snooze for each evening and handle any sleep issues, this sort of as obstructive snooze apnea.
    • Continue to keep liquor consumption to a minimum amount.
    • Handle pressure by means of rest attempts, this sort of as meditation and deep respiratory tactics.
    • Quit cigarette smoking.

    In addition to dwelling a coronary heart-healthy lifestyle, the major way to manage long-term hypertension is with prescription drugs that decrease blood stress. Some of the a lot more widespread antihypertensives contain:

    • Diuretics: These drugs minimize fluid amounts in the overall body to relieve the stress in the arteries, but can also decreased potassium stages, resulting in muscle-associated side consequences. Men and women with diabetes might experience spikes in blood glucose stages following taking diuretics.
    • Angiotensin-changing enzymes (ACE) inhibitors: These ACE inhibitors aid continue to keep the arteries comfortable and open to make improvements to blood flow and decrease blood tension. They’re typically safe and sound for most men and women, though anybody who’s pregnant or is thinking of becoming expecting must chat with a physician about an alternative medicine.
    • Angiotensin II receptor blockers: Typically recognised as ARBs, these help maintain blood vessels calm and open, nevertheless they do so by a distinct mechanism. ARBs should also not be employed through being pregnant.
    • Calcium channel blockers: These meds relieve the power by which the coronary heart contracts, so cutting down the stress of blood flowing though the arteries.

    A 2019 review of hypertension management also suggests that blood tension-reducing prescription drugs — also recognized as anti-hypertensives — are secure and effective treatment options for most persons and that they can be specifically useful in decreasing the possibility of cardiovascular problems, this kind of as heart attack and stroke.

    Serious hypertension is a popular, but treatable, condition that can impact older people of all ages and at times small children. Controlling significant blood pressure usually takes willpower and the skill to undertake coronary heart-healthier existence, together with a healthier diet and standard training. It commonly demands day-to-day medications, way too.

    If you stick to your medicine program and a schedule of wholesome eating and everyday workout, you may possibly steer clear of some of the far more serious problems of large blood tension.

  • Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review

    Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review

    According to Forbes, in October 2020, cannabidiol (CBD) sales in the United States reached $4.2 billion after the federal government legalized hemp-derived CBD in 2018 [1]. In addition, the World Health Organization (WHO) in 2019 re-classified CBD and <0.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of delta-9-tetrahydrocannabinol (THC) as not under international control and recognized its medical value in 2020 [2]. Hence, CBD is a rapidly expanding business expected to increase its value to $20 billion in 2025 [1].

    CBD is a nonintoxicating chemical ingredient from the Cannabis sativa plant [3]. CBD’s medical value was a hot topic for debate before being recognized in the medical field. One preparation of CBD approved by the U.S. Food and Drug Administration (FDA) is Epidiolex, an oral solution given to patients less than two years old to treat two rare and severe forms of seizure, Lennox-Gastaut syndrome and Dravet syndrome [4]. In addition, dronabinol [a synthetic delta-9-tetrahydrocannabinol (THC) product] and nabilone (like THC) were regulated by the FDA for the treatment of chemotherapy-induced nausea and vomiting [5]. Dronabinol is also used for AIDS-associated anorexia. With its federal legalization, CBD dispensaries continue to open one after another. People have more access to a wide variety of CBD products like cannabis flowers, tinctures, concentrates, topical lotion/creams, and edibles which are self-administered and with little or no supervision by a physician [6]. CBD oils provide relief for various conditions, including pain without intoxication [3]. Regulations of cannabis products remain a challenge for most countries.

    Chronic pain is a continuous or recurring pain for three months or longer experienced by a patient due to various causes. Different types of chronic pain are identified based on their nature, location, and characteristics. It is a significant cause of disability globally, and billions of dollars are spent annually to alleviate its outcomes [7]. While the opioid crisis increases, CBD’s role in pain management unveils as animal studies show promising evidence [8]. Further investigation and trials into CBD’s therapeutic value are ongoing due to its natural source, numerous usages, lower risk of addiction or dependency, and relative safety [7]. FDA regulation of CBD needs more clinical trials to determine its effectiveness and safety and should meet proper standards for authorization [9].

    This paper aims to answer the efficacy and safety of CBD in chronic pain using a systematic review of articles from five databases. This study will fill the existing gap and update knowledge on CBD’s role in chronic pain.

    Methods

    Protocol

    This descriptive systematic review was done according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 checklist [10]. Before the search of the databases, a protocol was made and shared with the research team to analyze and finalize. The main question of the review: What is the efficacy and safety of CBD in adult patients with chronic pain? The PICO strategy was used to formulate the question of this review. The review protocol can be acquired with a request addressed to the lead author.

    Search Strategy

    PubMed, PubMed Central (PMC), Medline, Cochrane Library, and ScienceDirect were utilized as the major databases and search engines. In PubMed, the search was done using keywords and a medical subject heading (MeSH). The keywords “Cannabidiol” and “chronic pain” were applied to obtain related literature. The MeSH strategy used in PubMed and PMC were: (“Cannabidiol/adverse effects”[Majr] OR “Cannabidiol/isolation and purification”[Majr] OR “Cannabidiol/metabolism”[Majr] OR “Cannabidiol/pharmacokinetics”[Majr] OR “Cannabidiol/pharmacology”[Majr] OR “Cannabidiol/poisoning”[Majr] OR “Cannabidiol/therapeutic use”[Majr] OR “Cannabidiol/toxicity”[Majr]) AND (“Chronic Pain/drug therapy”[Mesh] OR “Chronic Pain/prevention and control”[Mesh] OR “Chronic Pain/therapy”[Mesh]). Booleans “AND” and “OR” were used.

    Additionally, keywords such as Cannabidiol, CBD, Hemp, Marijuana, Chronic Pain, and other synonyms were applied to the other databases. Furthermore, other publications in the reference list and related studies were also examined to see if they were relevant and could be included in this review.

    There were a total of 2298 articles extracted from all the databases. PubMed, PMC, and Medline have 289 articles. The Cochrane Library and Science Direct gave 73 and 1936 articles, respectively. The databases were last accessed on April 2022.

    Eligibility Criteria

    A PRISMA flow diagram 2020 was used to show the study’s inclusion and exclusion of articles found in the databases used. The inclusion criteria for eligibility were: (i) studies in an adult population >18 years old; (ii) patients with pain symptoms of less than three months duration; (iii) all available preparations of CBD; (iv) human studies only; (v) publication in English; and (vi) publication in the last five years. Studies with pediatric patients, acute pain, and animal studies were excluded. Studies with no available full text were also excluded from the review.

    Data Collection Process: Synthesis, Extraction, and Management

    All titles of the articles initially obtained from databases were selected by applying the eligibility criteria set. Duplicates were eliminated. The titles were read, and unrelated articles were excluded. The abstracts of the remaining articles were further screened for relevance. The full text of the publications left was obtained, and those without full text were excluded.

    Quality Assessment in Included Studies

    The Scale for the Assessment of Narrative Review Articles (SANRA) [11], Assessment of Multiple Systematic Reviews (AMSTAR) [12], JBI tool for Case Reposts [13], New Castle Ottawa [14], and Risk of Bias 2 [15] in the Cochrane Risk Assessment Tool (RoB 2) were used to identify the eligible articles based on the kind of study for each publication. Two co-authors (NJ and NV) assessed the eligibility of the articles.

    Results

    Search Results

    Five databases (PubMed, PubMed Central, Medline, Cochrane Library, and ScienceDirect) were used to identify publications included in the review. Figure 1 is a PRISMA 2020 flow diagram showing how related studies included in the review were identified [10].

    Using MeSH and keywords like cannabidiol, CBD, hemp, and chronic pain, 2298 publications were obtained. PubMed, PMC, and Medline have 289 publications. The Cochrane Library and Science Direct listed 73 and 1936 publications, respectively. A preliminary screening was done. Upon checking for duplicates, 22 publications were excluded. Filters were applied using the exclusion and inclusion criteria to exclude 1704 publications. Other reasons include manual screening and protocol articles that eliminated 523 publications. Abstracts were screened, and 25 publications out of 49 were excluded. Fifteen full papers were retrieved, while nine were not. Two do not have full texts, and one is an animal study, hence excluded. The remaining publications were assessed for eligibility using the appropriate assessment tool. A total of 12 studies were found eligible for this review.

    Results of Quality Appraisal

    A summary of the studies and the quality appraisal tool used for each one is shown in Table 1.

    Kind of study Quality assessment tool Number of articles
    Review  SANRA 5
    Systematic review AMSTAR 3
    Case report JBI tool 1
    Observational New Castle Ottawa 2
    Randomized controlled trial Cochrane Bias Assessment tool (RoB 2) 1

    The study must get a 70{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to be eligible for this review. Detailed quality appraisals with the corresponding tools used for each study are shown below. Table 2 shows the use of SANRA for five review articles.

    Publication Boyagi et al. [8] Mauer et al. [5] VanDolah et al. [3] Mücke et al. [16] Fisher et al. [17]
    Justification of the article’s importance in the readership 2 2 2 2 2
    Statement of concrete aims or formulation of questions 1 1 1 2 1
    Description of the literature search 2 2 2 2 2
    Referencing 2 2 2 2 2
    Scientific reasoning 2 2 2 2 2
    Appropriate presentation of data 1 2 2 2 2

    AMSTAR is utilized to assess the eligibility of three systematic reviews shown in Table 3.

    Publication Rabgay et al.[18] Pagano et al. [19] Scuteri et al. [20]
    Did the research questions and inclusion criteria for the review include the components of PICO? Y Y Y
    Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review, and did the report justify any significant deviations from the protocol? Unclear Unclear Unclear
    Did the review authors explain their selection of the study designs for inclusion in the review? Y Y Y
    Did the review authors use a comprehensive literature search strategy? Y Y Y
    Did the review authors perform study selection in duplicate? Y Y Y
    Did the review authors provide a list of excluded studies and justify the exclusions? Unclear Unclear Unclear
    Did the review authors describe the included studies in adequate detail? Y Y Y
    Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review?  Y Y Y
    Did the review authors report on the sources of funding for the studies included in the review? Y Y Y
    Did the review authors account for RoB in individual studies when interpreting/discussing the results of the review? Unclear Y y
    Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review? Y Y Y

    Table 4 illustrates JBI as a quality assessment tool for case reports.

    Publication Diaz et.al. [21]
    Demographic characteristics Y
    History and timeline Y
    Presentation of clinical condition Y
    Diagnostic test and results Y
    Intervention and treatment Y
    Post-intervention clinical condition Y
    Adverse events N
    Take-away lessons Y

    New Castle Ottawa Tool is used to evaluate the eligibility of two observational studies in Table 5.

    Publication Capano et.al. [7] Boehnke et.al. [6]
    Representativeness of the exposed cohort * *
    Selection of the non-exposed cohort    
    Ascertainment of exposure * *
    Demonstration that outcome of interest was not present at start of study * *
    Comparability of cohorts on the basis of the design or analysis * *
    Assessment of outcome * *
    Adequacy of follow up of cohorts * *

    The RoB 2 tool is a revised Cochrane RoB employed for RCT assessment as shown in Table 6.

    Publication Lichtman et al. [22]
    Randomization process Low
    Deviations from the intended interventions (effect of assignment to intervention) Low
    Missing outcome data Low
    Measurement of the outcome Low
    Selection of the reported result Low
    Overall risk of bias  Low

    Data Extraction

    A total of 12 publications were found eligible for this systematic review. Each article included in this review was read and scrutinized. Relevant information was summarized in Table 7 to show an overview of each study collected from the databases.

    Author and year of publication Purpose of the study Number of patients/studies Type of study Main findings
    Boyaji et al. [8] To find an alternative treatment that is safer and more effective than opioids to combat chronic pain challenges. 7 studies Review Cannabidiol is a promising alternative to manage pain but hard to make recommendations due to the difficulty of attributing the therapeutic properties to CBD alone.
    Fischer et al. [17] To identify new scientific advances to make an updated ‘Lower Risk Cannabis Use Guideline’ (LRCUG).  Not specified Review The high-risk group (early adolescent, patient with comorbidity, and pregnant or breastfeeding women) can have a harmful outcome from CBD use; hence, lowering the risk factor can also lessen the adverse outcome.
    Mauer et al. [5] To know the safety, efficacy, and adverse effect of cannabis-based products on athletes. 2224 patients Review Recommendations from physicians are promising but hard to do since studies available are from non-athletic subjects.
    VanDolah et al. [3] To identify a non-intoxicating alternative to opioids in chronic pain management. 102 studies Review CBD and hemp oil have a positive potential benefit in managing chronic pain, and more research is required.
    Mücke et al. [16] To compare if cannabis-based medication versus placebo or conventional drugs are safe, efficient, and tolerable. 16 studies, 1750 patients Review Some patients with neuropathic pain may benefit from cannabis-based medicine (3rd or 4th line therapy), and no high-quality evidence to show how efficacious cannabis-based drugs are.
    Pagano et al. [19] To evaluate the safety level, dosing, and timing of CBD on healthy cells. 29 studies Systemic review Dose-dependent inhibition of cell viability above two micrograms while apoptosis is observed in 10 micrograms CBD. Anti-inflammatory effects and decreased ROS production were also noted.
    Rabgay et al. [18] To determine the role of the route of administration of cannabis and cannabinoids on pain and its side effects. 25 studies, 2270 patient Systemic review Among different routes of administration of THC/CBD, the Oro-mucosal route was dominant in controlling pain from different causes like cancer, neuropathic, and nociceptive pain.
    Scuteri et al. [20] To know the efficacy of cannabinoid-based products in ocular pain regimens. 4 studies Systemic review Preclinical studies are needed to establish the efficacy of CBD in ocular inflammation and neuropathic pain, although analgesia is observed using CBD oil. It is noted that the is analgesia as well on the topical formulation.
    Diaz et al. [21] To describe a patient with chronic pressure injury treated with medical cannabis oil (THC and CBD) for pain relief and sleep improvement. 1 patient Case report Medical Cannabis oil containing THC and CBD taken orally improves pain and sleep with direct or indirect effect on wound healing.
    Boehnke et al. [6] To describe naturalistic cannabis use routine and its benefits. 1087 patients Observational (cross-sectional) The risk and benefits of medical cannabis can be further observed when administration route profiles are used to make subgroups.
    Capano et al. [7] To determine the effect of CBD (full hemp extract) on chronic pain regarding the quality of life and opioid use. 131 patients Observational (prospective cohort) CBD improves pain, quality of life and sleep quality and decreases opioid use in patients who have chronic pain on narcotics.
    Lichtman et al. [22] To assess the use of nabiximols as an adjunct to opioids in advanced cancer patients with poorly controlled pain. 397 patients RCT Advanced cancer patients on lower opioid therapy with early intolerance to opioid may benefit more from CBD as adjunct medication, although CBD is not superior to placebo on primary efficacy.

    Discussion

    CBD is a fast-growing business following its federal legalization in 2018. With this, more people have gained access to CBD, especially those with chronic pain on pain medications, and have experienced promising outcomes. Hence, more research and studies are being done to give patients with chronic pain an efficacious and safe alternative to the existing kinds of pain medication available on the market.

    Cannabidiol versus Tetrahydrocannabinol

    The Cannabis sativa plant has many strains, but the more popular ones are marijuana and hemp. Phytocannabinoids can be extracted from the cannabis plant, and this active chemical, when combined with the receptor, affects the functioning of the body in many ways. THC and CBD are famous examples of these phytocannabinoids obtained from marijuana and hemp, respectively. THC attaches to cannabinoid receptor 1 (CB1) while CBD attaches to several receptors like CB receptors, transient receptor potential vanilloid 1, G protein-coupled receptor 55, and serotonin 5-HT1A [3]. CBD and THC have the same molecular formula, C21H30O2, and an almost identical molecular mass of 314.464 g/mol and 314.469 g/mol, respectively [23]. Figure 2 illustrates the structural formulas of CBD and THC, highlighting a vital difference between the two: a cyclic ring for THC and a hydroxyl group for CBD.

    This difference makes THC a potential partial agonist to the CB1 receptor and CBD a negative allosteric modulator, on the other hand [23]. The stimulation of CB1 receptors produces the psychotropic effects experienced with THC consumption but is not evident in CBD use. Metabolism is by the cytochrome P450 superfamily; hence many drug interactions are possible.

    In a review done by VanDolah et al., more studies focused on the benefits of prescribed THC drugs; on the other hand, four studies were linked to CBD’s potential therapeutic actions, safety, and adverse effects [3]. Some of the potential therapeutic actions of CBD include relief of chronic pain, sleep disorders, spasticity and Tourette syndrome, nausea and vomiting in chemotherapy, and weight gain in HIV patients, to name a few. Its adverse effects include liver toxicity, somnolence, decreased appetite, diarrhea, and low blood pressure [3]. In addition, Scuteri et al., a systematic review of four studies, revealed that CB2 agonist HU308 alleviates inflammation in the eyes by reducing uveitis-induced leukocyte adhesion and lipidome profile changes [20]. It also highlights the antinociceptive and anti-inflammatory effects of D8-THC, cannabidiol, derivative HU308, and the new racemic CB1 allosteric ligand [20]. Another study with 2224 patients by Maurer et al. revealed that the patients’ post-injury three and four-week use of cannabis after concussions resulted in a lower severity score but not faster recovery from concussion symptoms [5]. The case report of Diaz et al. on a patient with pressure injury exhibiting pain and sleep problems was given with three different medical cannabis oils (1 CBD-dominant and 2 THC-dominant) in increasing doses and revealed an improvement in sleep quality with a decrease in pain and anxiety [21]. An incidental wound improvement was noticed starting at two weeks post-treatment [21]. These studies highlighted different benefits of CBD on different areas of the body, making the potential value of the CBD product even greater. The studies complement each other in strengthening the value of CBD medically when used on different body parts.

    Regulation on Cannabis

    In the 2014 Agricultural Act, hemp and marijuana differences are notable, defining the legality of “industrial hemp” (Cannabis sativa L.) and any parts of the plant (with THC content <0.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} dry weight) for research purposes [3]. The use of medical cannabis is permitted in 37 states, four territories, and the District of Columbia and is prohibited in three states and one territory [24]. Figure 3 shows a clear picture of the regulation of cannabis per state in the United States.

    With more states opening their doors to the medical benefit of CBD, the issue of obtaining good quality CBD poses a risk for those who want to use it as an alternative to their current pain medications [25]. There is a high price tag on good quality CBD available, and affordable CBD products are not 100{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} reliable due to some manufacturers’ mislabeling issues about their exact content. In addition, the FDA still cannot impose strict regulations because CBD is not considered a pharmaceutical agent anymore [9].

    Efficacy and Safety of CBD

    In comparison to THC, CBD is a relatively new drug, and studies are limited to establishing its safety and efficacy. Moreover, the regulations surrounding the use of CBD are still highly debatable. In a systematic review of 229 studies done by Pagano et al., the effects of CBD on healthy cell characteristics such as cell viability, cell proliferation, wound repopulation, apoptosis, and cell cycle were tackled [19]. Dose-dependent administration showed a significant reduction of cell viability (above 2 mM); oral cells are inhibited at 10 mM, while cell proliferation inhibition is evident in all doses used (2, 6, and 10 mM). Cell migration decreased after giving 10 mM for 24 hours [19]. However, there was no significant change at 6 mM. Lastly, an increase in apoptosis is observed at 10 mM [19]. These observations show that a variable amount of CBD exerts different effects on a healthy cell. The dosage mainly dictates the extent of the results. It can be noted that a higher dose means more inhibition of cell processes but more stimulation of apoptosis.

    Furthermore, Rabgay et al. conducted a systematic review of 25 studies with 2270 patients regarding the different dosages and routes of administration for CBD [18]. They found out that cannabis and cannabinoids act on different types of pain depending on the dosage and route of administration. A low dose for pain relief was used for all studies reviewed and exhibited an average dose of 19.82 mg/day [18]. Furthermore, they discovered that the difference in the dosage administered elicited relief in different pain types, such as neuropathic pain, which is 23.56 mg/day, cancer pain, which is 19.69 mg/day, and nociceptive pain, which is 13.75 mg/day [18]. In addition, different routes of administration showed other forms of pain relief. The oromucosal route is THC/CBD and THC for neuropathic and cancer pain; the oral route is THC for cancer pain; and the inhalation of standardized cannabis with THC (SCT) for neuropathic and oral standardized cannabis extract with THC (SCET) for nociceptive pain [18]. Rabgay et al. concluded that there is no sufficient evidence to fully establish CBD’s efficacy on pain. In a review done by Boyaji et al. on seven studies using nabiximols (CBD+THC) spray as a medication for pain, four RCT studies concluded a positive effect on their pain while on nabiximols spray compared to placebo [8]. While Rabgay concluded that the evidence is insufficient to determine CBD’s efficacy in pain, Boyaji found it challenging to recommend CBD’s use in chronic pain. Access to pure CBD alone is the main reason for these conclusions.

    Some studies showed promising evidence to support the safety of CBD. A review of 16 RCTs conducted by Mücke et al. in 1750 adult participants with neuropathic pain showed that cannabis-based medicine might help achieve >50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} pain relief (primary outcome) compared with placebo [16]. It also increases nervous system adverse reactions, including psychiatric disorders, in 17{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of participants [16]. In addition, Fisher et al., in their review, made a recommendation to delay the use of cannabis until adolescence, avoid highly potent and widespread use, and prevent smoking cannabis from reducing its adverse effects like cardiovascular, physical, neurocognitive, psychosis, and mental problems [17]. In comparison, it can be deduced that proper dosage and route of administration are essential to gain the maximum effect from CBD use. CBD for pain relief still has a long way to be fully established, but the majority of studies possess promising outcomes. Therefore, formulation of the safety standard used for CBD could be a possibility soon if the growing evidence from more studies points to the efficiency and safety of CBD. Weighing the benefit versus the risk, backed by evidence, is a crucial step. The outcome of each study mentioned above can set a new playing field for pharmaceutical companies for drug development to explore and investigate using clinical trials in a large sample population.

    Chronic pain is persistent pain for more than or equal to three months in duration. It has been a complex issue, especially with its variable causes, the complexity of the associated symptoms, and opioid dependence [26]. Scientists and researchers are looking for alternative means to address chronic pain using more substantial evidence from clinical trials and observational studies. In an RCT done by Lichtman et al., nabiximols (THC+CBD) oromucosal spray was used as an adjunct treatment in 291 patients with advanced cancer and chronic pain on opioids [22]. The primary endpoint is the improvement of the average pain Numerical Rating Score (NRS) from baseline. NRS is calculated as the median difference between groups, which showed a positive value of 3.41{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (95{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} CI: 0.00{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}-8.16{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; p=0.0854) in favor of the nabiximols group. No statistical significance was noted in the primary outcome [22]. However, there is improvement in other aspects such as Subject Global Impression of Change (SGIC), Physician Global Impression of Change (PGIC), and Patient Satisfactory Questionnaire (PSQ) from nabiximols compared to the placebo group [22]. Clinical improvement was noticed in the nabiximols group, though not statistically significant.

    On the other hand, Capano et al. did a prospective cohort study (with 97 participants) about the effect of CBD hemp extract on patients with chronic pain taking opioid medication [7]. The primary outcome showed that at week 8, 50 out of 94 (53.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) had decreased their opioid medications [7]. The secondary outcome reported that 89 (94{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) improved quality of life as measured by pain and sleep-related open-ended questions. In a similar cross-sectional survey with 1087 patients, Boehnke et al. determined the relationship between the route of administration, CBD content, and timing of use in managing chronic pain [6]. It was noted that the younger population uses inhalation while older people prefer the non-inhalational route. The mixed (inhalation + non-inhalation) route is preferred (45{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of respondents), and this is attributed to the tailored pain relief experienced [6]. The content of CBD and timing of use showed that CBD with sedation effects (Indicas) is usually taken at night. Boehnke et al. reiterated in this study that subgroups in the sample population are essential in analyzing the results of CBD use [6]. These two observational studies mentioned above hold decent evidence of the positive effect of CBD on chronic pain, like reduced opioid intake and improved sleep. However, there is a challenge for patients to report the actual outcome observed because health insurance covers opioid medication but not CBD. Therefore, there is fear on the patients’ part about CBD’s availability after research and the financial cost they would have.

    Management of chronic pain poses many challenges. With the crisis of opioid use and dependence, medical providers and the government need to work hand in hand to urgently find alternatives to the treatment of chronic pain, whatever the reason may be [27]. More studies and research are rolling in to provide evidence-based solutions to the current crisis. However, more minor studies are focused on using pure CBD products, which are nonintoxicating. As this systematic review proceeded, challenges and questions about CBD use in chronic pain were revealed. More published reviews and studies show promising results for the effect of CBD on pain relief, yet there is difficulty in making any recommendations. Regulations and categories of CBD need to be updated to make clinical trials easier. When evidence of CBD’s pain relief is fully recognized, guidelines need to be applied to the health insurance business to lessen its financial burden on the patient. An opioid is covered by most insurance, while CBD is not. In addition, good-quality and affordable CBD products should be available once everything is in place.

    Limitations

    A systematic review of the efficacy and safety of pure CBD products was initially planned, but there are limited studies and articles available. Clinical trials on CBD are also scarce because it is relatively new and obtaining a good quality product is still a problem. In addition, it was difficult to find studies that focused on CBD alone since THC is often mixed with it. Access to free full-text papers is constrained as some good-titled articles need payment to gain access. The language of the publication is also limited to English. Although the business of medical marijuana and CBD dispensaries is old, most countries worldwide are still regulating it to make it legal. Hence, there is a limitation in conducting studies on CBD products.

  • Wisconsin’s ‘chronic Lyme’ patients embrace alternative treatments, rack up big bills

    Wisconsin’s ‘chronic Lyme’ patients embrace alternative treatments, rack up big bills

    Reading Time: 11 minutes

    Wisconsin Watch is a nonprofit newsroom that focuses on government integrity and quality of life issues. Sign up for our newsletter for more stories straight to your inbox. and donate to support our fact-checked journalism.

    Crystal Pauley, a former physician assistant, didn’t believe in so-called chronic Lyme disease — until she became sick.

    Many health care providers reject chronic Lyme disease as a diagnosis. One 2010 survey found that just six out of 285 primary care doctors surveyed in Connecticut — an epicenter for the tick-borne infection — believed that symptoms of Lyme disease persist after treatment or in the absence of a positive Lyme test.

    When Pauley worked for the La Crosse, Wisconsin-based Gundersen Health System, she remembered hearing about a friend from high school battling chronic Lyme in Australia. But she had her doubts. “I’m working in the medical field,” she said. “We’ve never learned about that.” 

    Years later, Pauley has changed her mind. Pauley tested positive for Lyme in 2020. She suffers from unrelenting fatigue, joint pain and brain fog. She walks up stairs sideways because of the unbearable knee pain. Pauley said she has become “pseudo-Lyme literate” because of her own personal journey.

    Pauley belongs to a cohort of patients with Lyme-like symptoms but negative test results or patients with positive test results who suffer from lingering symptoms long after treatment. They call it chronic Lyme disease, while the Centers for Disease Control and Prevention labels it as Post-Treatment Lyme Disease Syndrome (PTLDS). The CDC says there is no known treatment for the condition. 

    “Their symptoms are always real. They’re experiencing them,” said Dr. Joyce Sanchez, an infectious-disease associate professor at the Medical College of Wisconsin who treats Lyme patients with persistent symptoms. 

    “If someone is having physical symptoms and isn’t feeling listened to, then they’ll have mental health repercussions and then that will impact their physical well-being,” she said. “And then it’s a spiral that if you don’t address both components of health, you’re not going to make much progress on either side. And they will continue to feel sick.” 

    Wisconsin Watch talked with five Wisconsin patients, all women, who have been searching for validation and experimenting with personalized treatments as part of a long and sometimes grueling battle with the illness. The infection comes from tiny ticks primarily found in the northeastern United States, including in Wisconsin — which is a hot spot for Lyme, ranking No. 5 among states for Lyme cases in 2019.

    One of the five tested positive for Lyme using a two-step testing recommended by the U.S. Centers for Disease Control and Prevention. Three others tested positive using a test not recommended by the CDC. The fifth woman was diagnosed as possibly suffering from the disease by a “Lyme-literate” practitioner.

    Wide-ranging symptoms

    All of the five patients share commonalities. They’ve never noticed the signature “bull’s eye” rash around the tick bite, the hallmark of Lyme disease, which is seen in 70{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 80{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of patients. But relentless waves of rheumatologic, cardiac and neurological symptoms have flattened their lives. Some of them were previously fit and healthy. 

    Pauley, 37, who as a student cranked through medical textbooks, began having trouble remembering a simple medication direction. She put up sticky notes around her office to jar her memory.

    Alicia Cashman, 57, runs the Madison Area Lyme Support Group. She recalled unbearable pelvic pain beginning in 2010. “This causes pain of a magnitude that makes you want to die,” she said.

    The pain metastasized quickly. She felt joint pain, headaches, insomnia and extreme fatigue. “It was so bad that I just wanted to be in a dark room with no smell, no sound, no light. Your body has succumbed to this,” she said.

    Shelbie Bertolasi, 47, is a stay-at-home mother in Waukesha with four children ages 5 to 24. Until about seven years ago, she was healthy and stuck to a workout routine. 

    Shelbie Bertolasi was diagnosed with Lyme disease in July 2020 after suffering for many years with a variety of medical issues, including sweats, joint pain, rashes, intestinal issues and a miscarriage of twins. A naturopath finally recommended a Lyme test after she visited numerous doctors who she says failed to take her symptoms seriously. “I just want people to understand that Lyme is real. It’s not in our head. I want doctors to understand. I told doctors about my brain fog. My regular doctor wouldn’t even believe me.” She is seen at her home in Waukesha, Wis., on Dec. 1, 2021. (Coburn Dukehart / Wisconsin Watch)

    Bertolasi’s health steadily deteriorated starting in early 2015 when she miscarried twins. Then, she developed a high fever, with stomach and intestinal pain. She lost 30 pounds in a month due to constant diarrhea. Doctors flagged and treated excessive bacteria in her small intestine. She felt better but gradually was beset by continual pain in her joints, back, knees and hip. 

    Sometimes, she loses feeling in her feet. “It’s a nuisance when you’re in the middle of (driving), and you can’t feel the pedals that well,” she said.

    Judy Stevens, 52, a former school counselor and psychotherapist from Wauwatosa, says shortly after the loss of her father, she was hit by joint pain, brain fog, insomnia, hair loss and night sweats. She was an athletic person, a cross-country coach at school and a triathlete. 

    None of these women recalled seeing a tick, except Jessica Croteau, who lives in Rice Lake. The 34-year-old noticed a tick on her neck in the summer of 2019 at home and started to have flu-like symptoms, but she tested negative for Lyme. Croteau suffered bouts of low-grade fever, a stiff neck and gastrointestinal problems. She ended up visiting the emergency room when her blood pressure spiked. 

    Going down ‘rabbit holes’

    Often, chronic Lyme patients present multiple symptoms that make their diagnosis challenging. They bounce from one specialist to another to tackle each problem, but each diagnosis cannot explain all of the symptoms they are experiencing. 

    Cashman underwent an MRI because of her severe pelvic pain, and the results found two deflating ovarian cysts which can cause severe pain in the lower abdomen. But that diagnosis did not explain the unbearable pain that gravitated to her knees and to her head. She recalled that the swollen knee “got red hot to touch,” and she developed a fever. Cashman began to look for causes. “Not everything is Lyme, but everything can be (Lyme),” she said. “It’s a weird thing, but you got to go down these rabbit holes.” 

    Croteau saw specialists, including emergency physicians, a cardiologist, a kidney specialist and an immunologist. All the tests she took were negative for Lyme disease. She was told the problems may be related to psychological issues.

    “So basically, it’s been a timeline of two years of not being taken seriously, just pushed away — either told I can’t do anything for you (or) there’s nothing really wrong with you,” Croteau said.

    Judy Stevens, 51, was diagnosed with Lyme disease in July 2017, but thinks she may have had it since childhood. Her symptoms included brain fog, depression, insomnia, and she said she was often treated as a psychiatric patient by the more than 30 different doctors she saw. Prior to remission in 2020, she says she was taking more than 40 herbs and supplements a day. She estimated it cost her $25,000 to $50,000 a year to treat her Lyme disease. “It was a huge strain on us. I can’t even imagine not having the resources,” she said. “This is people’s reality. It’s really costly to get better and stay better.” She is pictured at her home in Wauwatosa, Wis., on Dec. 1, 2021. (Coburn Dukehart / Wisconsin Watch)

    A medical provider suggested that she seek counseling and increase her dose of anti-anxiety medicine. But the pain in her joints and wrists were real, and her knuckles often got swollen. The brain fog made it hard for her to punch in a phone number correctly. 

    Bertolasi saw a pain specialist, a psychiatrist, a spinal therapist and a neurologist. They diagnosed her with SI joint dysfunction. Back surgery, therapy and exercise relieved some of her pain, but her knees continue to hurt. She was told, “You’re getting older, (so) things don’t work as well as they used to.” 

    Unsatisfied, in 2019, Bertolasi saw a rheumatologist who ordered several tests, including for rheumatoid arthritis and lupus, and the results were all negative. And the forgetfulness has persisted; she has left her phone in the refrigerator. 

    “You’re just surrounded by this dark (mental) fog, and you just don’t know how to navigate your way through,” she said. 

    After seeing around 30 specialists, Stevens had a bag of medications, including many prescribed psychotropic drugs. She went on those drugs, and her psychiatric symptoms got worse. However, she doesn’t blame doctors, who generally specialize in one area of the body or a family of diseases. 

    “When you have a whole slew of symptoms, it’s hard for the physicians to dig deeper,” she said. 

    Sometimes, patients with waning and waxing symptoms are labeled as malingerers who are faking symptoms to get attention. “This is very common with people with Lyme,” Stevens said.

    Sanchez, the infectious disease doctor, worries that patients who do not get answers from mainstream medicine may gravitate toward unproven — and expensive — alternatives. But she sees no harm in some strategies that may offer relief, including meditation, tai chi, acupuncture or massage therapy.

    No quick fix

    Two of the five women interviewed by Wisconsin Watch have been diagnosed through the CDC’s two-step testing regimen: the ELISA test followed by the Western Blot, two different ways of looking for Lyme antibodies in the patient’s blood. Pauley tested positive for Lyme using the CDC’s recommended criteria, and Stevens tested positive on just one of the two tests.

    Two others used a laboratory that administers the same tests but uses less-stringent criteria to determine whether a person has Lyme. Cashman and Bertolasi both tested positive through that testing. A 2014 Columbia University study found that some labs using their own criteria reported more false positive results  — 57{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} — among people with no history of Lyme than the 25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} false-positive rate using CDC criteria. Croteau used three different laboratories but tested negative each time.

    With a Lyme disease diagnosis, Pauley took the standard treatment, doxycycline, for three weeks. 

    Judy Stevens is seen in the September 2015 photo when she says she was suffering from undiagnosed chronic Lyme disease. “I had lost 30 pounds and was almost put on a feeding tube. I clearly look very distressed and weak. At this time, I was diagnosed with an eating disorder, even though I was eating,” she said. Ten days later she had symptoms of Bell’s palsy in her face, and her husband took her to the emergency room because he thought she was having a stroke. She was told it was likely stress and was sent home. (Courtesy of Judy Stevens)

    But when she completed the antibiotic therapy, she felt even worse. While her memory has improved, she has developed muscle pain, and her knees hurt even more. She felt tired, saying she could sleep 10 to 16 hours a day. But her doctor, following standard protocol, has told her she is done with treatment.

    The same thing happened to Stevens. The doctor prescribed her 30 days of doxycycline and suggested that she seek a “Lyme-literate” doctor as she could not prescribe any longer course of antibiotics.

    Stevens’ doctor followed CDC guidance, which recommends against prolonged antibiotic treatment, saying the harm outweighs the benefit. Sanchez echoed the argument, saying that doctors must weigh the risks and benefits of antibiotics, just like other prescribed medications.

    “If we don’t see any plus side benefit to it, then we’re only exposing people to unnecessary risks,” she said. “Nothing comes with a free lunch. It’s important to be thoughtful about the right antibiotic at the right dose for the right amount of time.”

    She also said some antibiotics could bring down inflammation as a side effect, making some patients feel better. This is also the point at which some patients begin experimenting with treatments that mainstream medicine does not recognize.

    Sufferers try unconventional treatments

    Cashman, living in Cataract, Wisconsin was also diagnosed with Bartonella, or Cat scratch disease, and went through five years of “systemic, holistic” treatments, which included a host of herbs, antibiotics, a high dose of vitamin C and supplements. She also received ozone therapy and laser therapy for pain relief. She is now nearly symptom-free, but still deals with spine stiffness. 

    Alicia Cashman shows a variety of treatments she uses for her chronic Lyme disease. Seen on her counter is a jar of homemade Japanese knotweed tincture, as well as a bottle of Dimethyl Sulfoxide (DMSO) and MSM power, which she puts into a homemade pain ointment — seen in the jar on the right. “We call it a ‘do it yourself disease’ because you have to be an active participant in your own healing,” she says. “I attribute my health today to doctors who were willing to work outside the box.” Photo taken Jan. 31, 2020. (Coburn Dukehart / Wisconsin Watch)
    A bottle of A-Bart, an herbal supplement, is seen at the home of Shelbie Bertolasi in Waukesha, Wis., on Dec. 1, 2021. The bottle costs $90 and is just one of the many supplements Bertolasi takes to treat her chronic Lyme disease. “We spend tons and tons of money on treatments. There are things my family can’t do because of all the money we have to spend to treat the Lyme,” she says. (Coburn Dukehart / Wisconsin Watch)

    Stevens found two Lyme-literate doctors in Wisconsin who are versed in both Western and alternative medicine. She said she was co-infected with Relapsing Fever, Babesiosis and Bartonella. She said her treatments are highly individualized, and her doctors tweak her therapies from time to time. At one point, Stevens was on more than 40 types of herbs and supplements.

    “I’m living proof that I got better as a result of all those herbal treatments,” she said. “I was not on antibiotics for four or five months.” 

    Bertolasi turned to a Lyme-literate doctor who also treats one of her friends with similar symptoms. Besides Lyme, she was also diagnosed with Bartonella. She has completed a 14-month course of antibiotics. Now, besides taking herbal supplements, Bertolasi follows a strict diet excluding alcohol, dairy, gluten and sugar to reduce inflammation in her body.

    Shelbie Bertolasi explains the variety of supplements she takes to treat her Lyme disease. Bertolasi has spent the past few years treating her symptoms with a variety of supplements, some of which cost anywhere from $30 to $90 a bottle. She estimates she spends about $500 a month on supplements. She is seen at her home in Waukesha, Wis., on Dec. 1, 2021. (Coburn Dukehart / Wisconsin Watch)

    She said she is at least 80{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} better than about a year ago. Her memory has somewhat returned. Still, brain fog waxes and wanes — as does pain in her joints and lower back.

    Croteau tested negative with three Lyme disease tests, but she was diagnosed by a Lyme-literate doctor with Bartonella and “questionable” Lyme disease. The doctor prescribed her doxycycline, triggering a severe reaction that Lyme-infected patients sometimes experience during treatment. 

    When Croteau found herself pregnant, the doctor suggested she take amoxicillin and clindamycin in low doses during her pregnancy. She stopped taking them after giving birth to her second child in late October 2021 and has been symptom free for the following two months. Croteau said her symptoms have returned since January, including fatigue and brain fog, neck stiffness, headache and nausea. She cares for her newborn at home and hasn’t started any treatment due to financial constraints.  

    ‘A rich person’s disease’

    Since chronic Lyme is not a recognized disease, it’s difficult to get insurance coverage, so patients are usually stuck paying out of pocket for treatment.

    Pauley, who lives in Woodstock, Illinois, is still searching for affordable treatments.

    Her dementia-like symptoms made it impossible to continue working as a veterinary assistant, and she quit her veterinary clinic job in 2020. Previously, she had quit her physician assistant job in La Crosse and moved back to Illinois. 

    “It was hard,” she said. “I went from the middle-upper class to the poverty line.” 

    She went to see a Lyme-literate doctor in Milwaukee in August, when she was also suspected to have Bartonella. Pauley was charged $525 per hour for the initial consultation fee, not counting testing fees and supplements. She was irritated to hear the doctor refer to it as “a rich person’s disease.”

    “It’s hard to understand any doctors that charge like Beverly Hills lifestyle out in the Midwest,” she said. “We’re not celebrities, and I don’t get paid 30 million per film.” 

    Stevens said her average costs out of pocket range from $25,000 to $50,000 a year. “It was a huge strain on us,” she said. “This is why a lot of people can’t get better, because they can’t afford it.” 

    Cashman knows the financial burdens chronic Lyme patients bear, too.

    She estimates she has spent $150,000 out of pocket for treatments that she and her husband — who also is a chronic Lyme patient — have taken over the years. Cashman has found ways to reduce the costs by, for example, buying pounds of ground herbs and making her own capsules at home.

    Although all five women interviewed by Wisconsin Watch have tried unconventional treatments, they say they are skeptical about anyone who claims their chronic illness can be cured quickly. 

    Alicia Cashman leads a meeting of the Madison Area Lyme Support Group at the East Madison Police Station in Madison, Wis., on Feb. 8, 2020. About 13 other people were in attendance, some of whom had driven from more than an hour away. The group shared personal experiences with chronic Lyme disease. Also pictured is Olivia Parry of Madison, Wis. (Coburn Dukehart / Wisconsin Watch)

    “(If it) is just a quick fix to make money, and I’m just very leery of it,” Bertolasi said. 

    And they are using their experiences to help others. Pauley has become an advocate for lower health care costs. Bertolasi is writing a Lyme-friendly cookbook to chronicle recipes that have worked for her. 

    Although Stevens said being a chronic Lyme patient is “like a full-time job,” she wants people to know there is hope. 

    “You can be in terrible shape, but you can get better,” Stevens said. “It’s really easy to go down the road of ‘poor me,’ but it is possible to get better. There is hope. You can reach remission.”

    The nonprofit Wisconsin Watch (www.WisconsinWatch.org) collaborates with WPR, PBS Wisconsin, other news media and the University of Wisconsin-Madison School of Journalism and Mass Communication. All works created, published, posted or disseminated by Wisconsin Watch do not necessarily reflect the views or opinions of UW-Madison or any of its affiliates.

    Republish our articles for free, online or in print, under a Creative Commons license.

    Close window

    Republish this article

    Scroll down to copy and paste the code of our article into your CMS. The codes for images, graphics and other embeddable elements may not transfer exactly as they appear on our site.

    You are welcome to republish our articles for free using the following ground rules.

    • Credit should be given, in this format: “By Dee J. Hall, Wisconsin Watch”
    • If published online, you must include the links and link to wisconsinwatch.org
    • If you share the story on social media, please mention @wisconsinwatch (TwitterFacebook and Instagram)
    • Don’t sell the story — it may not be marketed as an individual product.
    • Don’t sell ads against the story. But you can publish it with pre-sold ads.
    • Your website must include a prominent way to contact you.
    • Additional elements that are packaged with our story must be labeled.
    • Users can republish our photos, illustrations, graphics and multimedia elements ONLY with stories with which they originally appeared. You may not separate multimedia elements for standalone use. 
    • If we send you a request to change or remove Wisconsin Watch content from your site, you must agree to do so immediately.

    For questions regarding republishing rules please contact Andy Hall, executive director, at [email protected]

    1

  • Cannabis for chronic pain relief: How effective is it?

    Cannabis for chronic pain relief: How effective is it?

    • Hashish can at times be used as a system of persistent soreness relief, but there is a ton about cannabis’ well being gains and related dangers that scientists even now don’t comprehend.
    • New research located that some hashish merchandise made up of THC and CBD factors might support with the small-phrase advancement of persistent soreness.
    • The conclusions also advise a danger of sedation and dizziness involved with use, and there desires to be additional information on the very long-term influence.

    Lots of persons encounter long-term discomfort or pain that lasts for an prolonged period of time. Professionals are continually looking into new methods of suffering reduction and new medicine alternatives. One spot of fascination is the use of cannabis items as a strategy of suffering reduction.

    A current systematic evaluation published in the Annals of Interior Drugs located that hashish products and solutions could possibly help take care of chronic agony in the short phrase. Even so, professional medical pros need to have to weigh this against the potential disadvantages of enhanced dizziness and sedation. It is also unclear whether or not these merchandise are valuable in the extended time period.

    Persistent suffering lasts for months or extended, and tens of millions of adults in the U.S. working experience serious pain. For the reason that quite a few men and women practical experience long-term ache, gurus are constantly operating to assess prospective treatments and therapies. As experts continue to study the medicinal employs of cannabis, one particular space of fascination is how doctors could use it to treat chronic suffering.

    Cannabis is a plant, and individuals can use distinctive plant portions to produce several merchandise. The two major compounds of cannabis are cannabidiol (CBD) and tetrahydrocannabinol (THC).

    Some goods have both of those THC and CBD. The CBD part does not result in brain-altering results, whilst the THC portion causes the high persons to expertise when they use cannabis. Some of these related merchandise are obtainable in the U.S., although some are not. Presently, the Meals and Drug Administration has approved utilizing two medicines that comprise THC: Marinol and Syndros.

    This systematic overview sought “To assess the gains and harms of cannabinoids for continual pain.” The phrase Cannabinoids refers to compounds that incorporate equally THC and CBD.

    Researchers utilized quite a few databases to accumulate the experiments they reviewed. They integrated studies published in English that resolved the use of hashish products and solutions as a procedure for persistent soreness. Especially, the examine involved a abide by-up or treatment time of 4 months or far more. The examination integrated placebo-controlled randomized controlled trials and cohort scientific studies in which the use of cannabis had a concurrent regulate team.

    They incorporated a whole of 25 experiments in their investigation. Researchers examined the merchandise used in the scientific studies and looked at the THC-to-CBD ratio. Did the products comprise a significant THC amount of money and a low CBD amount, was the total about equivalent or did the solution have a low THC amount and a significant CBD quantity?

    The benefits of the review had been rather missing. The data was inadequate for some products and solutions to ascertain if they successfully handled continual soreness. Nonetheless, researchers did discover some results that supported the efficiency of hashish goods:

    • Synthetic oral products and solutions with a superior THC-to-CBD ratio could lead to short-term chronic suffering relief.
    • Sublingual extracted cannabis products with nearly equal THC-to-CBD proportions could possibly be connected with short-term enhancements in chronic ache.

    Nonetheless, they located that individuals who use these items may possibly also encounter an increased hazard for dizziness and sedation, which physicians will will need to weigh towards the likely positive aspects. Total, they also discovered that authorities require to conduct much more experiments about the very long-time period outcomes of cannabis use.

    Study author Marian S. McDonagh located the absence of info stunning. She described:

    “With so substantially excitement all around hashish-associated items, and the uncomplicated availability of leisure and medical marijuana in several states, buyers and sufferers may well think there would be more proof about the benefits and side results. Regrettably, there is really little scientifically valid analysis into most these items.”

    Professor Winston Morgan, pharmacology and toxicology specialist with the University of East London, not associated with the research, mentioned the next to Healthcare Information Right now:

    “For any new mediation it need to improve on recent treatments in phrases of each efficacy and basic safety. For decades cannabinoids have promised but never ever really deliver. This evaluation which requires an attention-grabbing solution on the advantages and harms of cannabinoids for continual agony, advise that only average added benefits can be attained with merchandise with higher THC ratios, but these are far more probable to result in adverse effects. Regrettably these adverse outcomes may well also restrict extended phrase use.”

    This systematic critique yielded some beneficial information. Even so, it also experienced quite a few limitations. Initial of all, researchers built particular selections throughout the review process that may perhaps have impacted the evaluate benefits, these kinds of as how sure cannabis merchandise ended up classified. The procedures of examining the details do have a danger of imprecision.

    They have been also unable to assess publication bias on quite a few results owing to out there information and did not contain studies that weren’t prepared in English. Last but not least, different reports utilized distinctive interventions, and some scientific tests lacked particulars. For some merchandise, there was basically insufficient proof.

    Scientists of the systematic overview approach to update the overview quarterly so that they can insert new proof as it emerges. In general, this paper demonstrates some of the recent understandings of cannabis and the need to have for even further analysis. Physicians can take a look at evaluations like this a single to assist guideline their clients in the remedy of chronic agony.

    Analyze author Devan Kansagara, MD, M.C.R defined:

    “This new dwelling proof assessment is just the sort of resource clinicians need to explain for people the
    locations of likely guarantee, the cannabis formulations that have been analyzed and, importantly, the
    major gaps in know-how.”